Acute disease
MONDO:0020683Disease having a short and relatively severe course.
Also known as: acute disease, acute diseases, disease, acute
4495 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
Showing the 400 most recently updated of 988 trials in this tab.
-
Engineered immune cells take aim at Hard-to-Treat leukemias
⭐️ CURE ⭐️ CompletedThis trial is testing a new type of immune cell therapy called CD123 CAR-NK cells in people with relapsed or refractory acute myeloid leukemia (AML) or blastic plasmacytoid dendritic cell neoplasm (BPDCN). The cells are designed to find and attack cancer cells that carry a protei…
Phase: PHASE1, PHASE2 • Sponsor: Chongqing Precision Biotech Co., Ltd • Aim: ⭐️ CURE ⭐️
Last updated Aug 07, 2026 00:00 UTC
-
Can a targeted drug plus donor immune cells fight back against relapsed leukemia?
⭐️ CURE ⭐️ CompletedThis trial is for adults with relapsed or refractory acute myeloid leukemia (AML) who have no standard curative options. Researchers are testing whether giving the drug gemtuzumab ozogamicin followed by an infusion of donor white blood cells can stimulate the immune system to att…
Phase: PHASE1, PHASE2 • Sponsor: Brown University • Aim: ⭐️ CURE ⭐️
Last updated Jul 25, 2026 00:00 UTC
-
Personalized leukemia vaccine aims to outsmart relapse
⭐️ CURE ⭐️ CompletedThis study tests a personalized vaccine made from a patient's own leukemia cells fused with immune cells, combined with a drug that blocks PD-1, to help the immune system recognize and destroy any remaining leukemia cells after chemotherapy. The goal is to prevent the cancer from…
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: ⭐️ CURE ⭐️
Last updated Jul 16, 2026 00:00 UTC
-
Can a drinkable vaccine stop Shigella's grip?
⭐️ VACCINE ⭐️ CompletedThis trial tests an experimental oral vaccine, WRSs2, designed to protect against Shigella sonnei, a common cause of severe diarrhea. Healthy adults aged 18-49 receive either the vaccine or a placebo, then are later exposed to the live bacteria in a controlled setting to see if t…
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Aug 12, 2026 00:00 UTC
-
New shigella vaccine shows promise for infants in phase 2 trial
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine called Shigella4V2 to protect infants against shigellosis, a severe diarrheal disease. Researchers gave the vaccine to 110 healthy 9-month-old babies to check its safety and how well it triggers an immune response. The goal is to find the best dose…
Phase: PHASE2 • Sponsor: LimmaTech Biologics AG • Aim: ⭐️ VACCINE ⭐️
Last updated Aug 09, 2026 00:00 UTC
-
Could a Lower-Dose polio vaccine help eradicate the disease?
⭐️ VACCINE ⭐️ CompletedThis study tests a hexavalent vaccine that protects against six diseases, including polio, but uses a lower dose of the inactivated polio vaccine (IPV). The goal is to see if this reduced-dose version works as well as the standard full-dose vaccine in infants. Around 1,500 health…
Phase: PHASE3 • Sponsor: Serum Institute of India Pvt. Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 03, 2026 00:00 UTC
-
New vaccine aims to protect infants from deadly diarrhea
⭐️ VACCINE ⭐️ CompletedThis study tests a new vaccine called Shigella4V, designed to protect against shigellosis, a severe diarrheal disease. Researchers are giving the vaccine to healthy adults, children, and 9-month-old infants to check its safety and whether it triggers a strong immune response. Dif…
Phase: PHASE1, PHASE2 • Sponsor: LimmaTech Biologics AG • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 14:03 UTC
-
New vaccine aims to shield against multiple coronaviruses at once
⭐️ VACCINE ⭐️ CompletedThis study tested an experimental vaccine called VBI-2901a in 103 healthy adults aged 18-64 who had already received at least two doses of a licensed COVID-19 vaccine. The vaccine is designed to protect against three coronaviruses: SARS-CoV-2 (which causes COVID-19), SARS-CoV-1, …
Phase: PHASE1 • Sponsor: VBI Vaccines Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:31 UTC
-
Chinese COVID-19 vaccine trial shows strong immune response in 960 volunteers
⭐️ VACCINE ⭐️ CompletedThis Phase 2 trial tested the BNT162b2 mRNA vaccine in 960 healthy Chinese adults aged 18 to 85. Participants received two doses of either the vaccine or a placebo, 21 days apart. The main goal was to check safety and measure the immune response, specifically neutralizing antibod…
Phase: PHASE2 • Sponsor: BioNTech SE • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 11:03 UTC
-
Immune cells supercharged to fight cancer: early trial shows promise
Disease control CompletedThis early-phase trial tested whether giving patients their own natural killer (NK) cells, boosted by the drug bortezomib, is safe for treating advanced cancers like leukemia, lung, and pancreatic cancer. Thirty-five adults whose cancers had not responded to standard treatments r…
Phase: PHASE1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Aug 18, 2026 02:00 UTC
-
Can a pill keep blood cancer at bay after a stem cell transplant?
Disease control CompletedThis phase III trial is testing whether taking oral azacitidine as a maintenance therapy after an allogeneic stem cell transplant can help prevent relapse in people with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). Participants are randomly assigned to receive…
Phase: PHASE3 • Sponsor: University of Birmingham • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
A tiny chest patch could tell doctors who's ready to leave the hospital
Disease control CompletedThis trial tests whether continuously monitoring patients in the acute admission ward with a small chest-worn sensor can help doctors decide who is safe to go home. The sensor tracks heart rate, breathing, posture, and activity. Researchers will compare outcomes like discharge ra…
Phase: NA • Sponsor: Rijnstate Hospital • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Could a higher steroid dose help preterm babies breathe easier?
Disease control CompletedThis study looks at whether a higher dose of dexamethasone, a steroid given to pregnant women at risk of early birth, helps preterm babies' lungs mature better. Researchers are comparing babies born between 26 and 36 weeks whose mothers received either 12 mg or 6 mg of dexamethas…
Sponsor: Stella Maris Women and Children Hospital • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can a modified enzyme starve Hard-to-Treat blood cancers?
Disease control CompletedThis phase 1 trial is testing an investigational drug called AEB1102 in adults with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) that has returned or stopped responding to standard treatments. AEB1102 is a modified human enzyme that breaks down arginine, an amin…
Phase: PHASE1 • Sponsor: Immedica Pharma AB • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
Disease control CompletedThis trial is testing whether a chemotherapy drug called treosulfan, given in different doses along with fludarabine, can safely prepare patients with advanced blood cancers for a stem cell transplant. The study focuses on patients who are not eligible for the standard, more inte…
Phase: PHASE1, PHASE2 • Sponsor: medac GmbH • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New drug cocktail shows promise for rare bone marrow cancer
Disease control CompletedThis early-stage trial tests a combination of two drugs, venetoclax and azacitidine, in people with a serious type of myelodysplastic syndromes (MDS) who have not had treatment before. The goal is to find the safest dose and see how well the drugs work together to control the dis…
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a new drug offer hope for blood cancers when chemo fails?
Disease control CompletedThis trial is testing an experimental drug called BST-236 in adults with acute myeloid leukemia (AML) or high-risk myelodysplastic syndromes (MDS) that have come back or not improved after initial treatment. Participants receive BST-236 as a one-hour intravenous infusion for six …
Phase: PHASE2 • Sponsor: Groupe Francophone des Myelodysplasies • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Blood-Filtering therapy may tame rare brain inflammation in children
Disease control CompletedThis trial investigates whether a blood-filtering procedure called immunoadsorption (IA), combined with the drug rituximab, can improve neurological function in children aged 0-18 with severe anti-NMDAR encephalitis. Participants receive 10 IA sessions over 28 days plus weekly ri…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a Community-Based rehab program boost heart recovery after a first attack?
Disease control CompletedThis trial tests whether a cardiac rehabilitation program based on a socio-ecological model can improve recovery in adults who have had a first heart attack and undergone a stent procedure. The program goes beyond standard care by providing guidance on exercise, diet, medication,…
Phase: NA • Sponsor: Jinzhou Medical University • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a Platelet-Boosting drug speed recovery for older leukemia patients?
Disease control CompletedThis phase II trial investigates whether eltrombopag, a drug that stimulates platelet production, can help older adults with acute myeloid leukemia (AML) recover their platelet counts faster after initial chemotherapy. Older patients often experience slow platelet recovery, which…
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Engineered donor cells take aim at returning blood cancers
Disease control CompletedThis early-phase study tested a new approach for people whose B-cell cancers (like lymphoma or leukemia) came back after a donor stem cell transplant. Researchers took white blood cells from the original donor, genetically modified them to recognize and attack cancer cells, and g…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Which citrate solution minimizes metabolic chaos in kidney therapy?
Disease control CompletedThis trial tests two different concentrations of citrate solution used to prevent blood clotting during continuous kidney replacement therapy in critically ill patients with acute kidney injury. The goal is to see which concentration leads to fewer metabolic complications, such a…
Phase: NA • Sponsor: University Hospital, Antwerp • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Chemotherapy-Free combo aims to boost remission in younger AML patients
Disease control CompletedThis phase 2 trial is testing whether a combination of two drugs, venetoclax and azacitidine, can effectively treat adults aged 18 to 59 who have been newly diagnosed with acute myeloid leukemia (AML) and have not yet received any treatment. Participants take both drugs in cycles…
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can timed lung 'Recruitment' maneuvers protect Preemies' lungs?
Disease control CompletedThis trial tests whether performing stepwise, oxygenation-guided lung recruitment maneuvers at regular intervals during high-frequency oscillatory ventilation (HFOV) can improve oxygen levels in extremely preterm infants born before 28 weeks of gestation. The study compares this …
Phase: NA • Sponsor: Medical University of Vienna • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New drug aims to shield kidneys from dye damage during heart surgery
Disease control CompletedThis study tests whether the drug APX-115 can prevent kidney injury caused by contrast dye used in heart procedures. About 230 adults with kidney disease will receive either the drug or a placebo before and after their procedure. The goal is to see if the drug reduces kidney dama…
Phase: PHASE2 • Sponsor: Aptabio Therapeutics, Inc. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a Diaphragm-Sensing ventilator mode reduce breathing asynchrony?
Disease control CompletedThis trial compares two modes of noninvasive ventilation in adults with acute respiratory failure: standard pressure support (PSV) and a newer mode called Neurally Adjusted Ventilatory Assist (NAVA). NAVA uses electrical signals from the diaphragm to trigger breathing support, wh…
Phase: PHASE1 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Better brain zaps: new study tests precision targeting for depression treatment
Disease control CompletedThis study tests whether using MRI to guide transcranial magnetic stimulation (TMS) works better than the usual scalp-based method for treating depression. It involves 54 participants, including those with treatment-resistant depression and others with COVID-related distress. The…
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a pain block ease lung strain in severe pancreatitis?
Disease control CompletedThis trial tests whether epidural analgesia—pain medicine delivered near the spinal cord—can help people with severe acute pancreatitis breathe better and avoid needing a breathing machine. About 148 ICU patients with severe pancreatitis will be randomly assigned to receive eithe…
Phase: PHASE3 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Letting patients decide when to stop antibiotics: a pilot study
Disease control CompletedThis pilot study tested whether women with kidney infections could safely stop antibiotics once their symptoms resolved, instead of taking a full 10-day course. 35 women were randomly assigned to either standard treatment or a patient-directed approach. The main goal was to see i…
Phase: PHASE4 • Sponsor: Brett A Faine • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a week of antibiotics beat a kidney infection?
Disease control CompletedThis trial tests whether a 7-day antibiotic course—starting with an intravenous dose of ceftriaxone followed by oral cefixime—can effectively treat acute uncomplicated pyelonephritis (a kidney infection) in women aged 18 to 65. The goal is to see if this shorter regimen works as …
Phase: PHASE4 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a smart drug missile tame Hard-to-Treat leukemia?
Disease control CompletedThis trial is investigating whether a targeted drug called CMC-544 (inotuzumab ozogamicin), given alone or later combined with rituximab, can control acute lymphoblastic leukemia (ALL) that has returned or not responded to standard treatment. The study enrolls adults and older ch…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Can a quick shot stop a heart attack in its tracks?
Disease control CompletedThis phase 2 trial tests whether a single injection of selatogrel can rapidly prevent platelets from clumping together in adults having a heart attack. Participants receive either an 8 mg or 16 mg dose in the thigh, and researchers measure how quickly platelet activity drops. The…
Phase: PHASE2 • Sponsor: Viatris Innovation GmbH • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Herbal granules may knock out cold symptoms in three days — a rigorous trial puts them to the test
Disease control CompletedThis phase 3 trial tests whether Jinhua Qinggan Granules, a traditional Chinese herbal medicine, can eliminate symptoms of acute upper respiratory infections (like fever, sore throat, and congestion) within three days. About 273 adults with early-stage cold or flu will receive ei…
Phase: PHASE3 • Sponsor: University of Karachi • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can a lung protein tame severe graft-versus-host disease?
Disease control CompletedThis phase 3 trial investigates whether adding alpha-1 antitrypsin (AAT) to standard corticosteroid therapy improves outcomes for people with high-risk acute graft-versus-host disease (GVHD) after a stem cell transplant. Participants receive either AAT plus steroids or a placebo …
Phase: PHASE3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Could a diet and exercise program help childhood leukemia survivors live healthier?
Disease control CompletedThis trial tests whether a personalized diet and exercise program, delivered by phone and online, can help adult survivors of childhood leukemia who are overweight or obese lose weight. Participants are randomly assigned to either the active coaching program or a self-directed ap…
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New drug gilteritinib takes on standard therapy in FLT3 leukemia trial
Disease control CompletedThis Phase 2 trial tests whether the oral drug gilteritinib works better than midostaurin for adults with a specific genetic subtype of acute myeloid leukemia (FLT3-mutated AML). All 181 participants also receive standard chemotherapy. The goal is to see which drug leads to more …
Phase: PHASE2 • Sponsor: PrECOG, LLC. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a pill tame a common blood cancer in the real world?
Disease control CompletedThis study follows about 269 people with chronic lymphocytic leukemia (CLL) who are starting venetoclax, a targeted pill. Researchers will track how well the drug shrinks or controls the cancer over the first year, and how long it takes before patients need another treatment. The…
Sponsor: AbbVie • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Ear zaps during heart attack may shield the heart from damage
Disease control CompletedThis trial investigates whether gentle electrical stimulation of the ear (specifically the vagus nerve area) during emergency heart attack treatment can reduce heart muscle damage and improve recovery. Researchers are enrolling 110 adults having their first major heart attack who…
Phase: NA • Sponsor: Bakulev Scientific Center of Cardiovascular Surgery • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Leukemia drug cocktail aims to boost remission in High-Risk patients
Disease control CompletedThis study tests whether adding the targeted drug venetoclax to standard chemotherapy helps more adults with acute myeloid leukemia (AML) achieve remission. It enrolls people aged 18 to 65 with intermediate- or high-risk AML who have not yet been treated. The main goal is to see …
Phase: PHASE2 • Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Ancient herbal combo could speed healing in pancreatitis
Disease control CompletedThis study tests whether adding a traditional Chinese herbal enema (Tongfu Qinghua Decoction) and an external herbal powder (Ruyi Jinhuang Powder) to standard medical care can help adults with acute pancreatitis recover faster. The trial enrolled 100 people aged 18 to 75 with the…
Phase: NA • Sponsor: The Third Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Avatar game teaches heart attack patients how to recover
Disease control CompletedThis study tests whether an interactive avatar-based game on a tablet can help people who have had a heart attack learn how to manage their health after leaving the hospital. Participants are randomly assigned to either standard face-to-face discharge education or the tablet game…
Phase: NA • Sponsor: Suleyman Demirel University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could conscious sedation replace general anesthesia for gallbladder drainage?
Disease control CompletedThis study tests whether endoscopic ultrasound-guided gallbladder drainage can be safely performed using conscious sedation given by the endoscopist, instead of deep sedation or general anesthesia. The trial enrolls elderly, high-risk patients with acute cholecystitis who are not…
Sponsor: Azienda Unita Sanitaria Locale di Piacenza • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Could a targeted drug keep AML in check?
Disease control CompletedThis phase III trial tests whether the drug tipifarnib can prevent acute myeloid leukemia (AML) from coming back in patients who are already in remission. Participants include adults over 60 in first remission, those in second or later remission, or those who achieved remission a…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Gentler breathing support may help preterm babies avoid breathing tubes
Disease control CompletedThis trial compares two noninvasive breathing support methods—heated humidified high-flow nasal cannula (HHHFNC) and nasal continuous positive airway pressure (nCPAP)—in premature infants (born at 28-34 weeks) with moderate respiratory distress syndrome. The goal is to see which …
Phase: NA • Sponsor: Kayseri City Hospital • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Heart attack patients: which blood thinner is safer?
Disease control CompletedThis study looked at over 17,000 people who had a heart attack to compare two blood thinners: prasugrel and ticagrelor. Hospitals switched from ticagrelor to prasugrel in a stepwise way to see which drug better prevents death, another heart attack, or stroke. The goal is to find …
Phase: PHASE4 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Hand vs. wrist: which route to the heart is safer during a heart attack?
Disease control CompletedThis trial compares two ways to insert a catheter into the heart during a heart attack: through the wrist (conventional) or through the hand (distal). The goal is to see which method is faster and causes fewer complications, such as blocking the wrist artery. About 550 heart atta…
Phase: NA • Sponsor: University Hospital of Patras • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New drug combo aims to outsmart aggressive leukemia
Disease control CompletedThis trial tests whether adding the targeted drug ponatinib to standard chemotherapy (cytarabine) can help prevent relapse in adults with a specific, high-risk genetic form of acute myeloid leukemia (FLT3-ITD AML) who are already in first remission. The study includes two age gro…
Phase: PHASE1, PHASE2 • Sponsor: Versailles Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New hope for frail AML patients: stronger chemo regimens tested
Disease control CompletedThis study tests whether giving full-strength chemotherapy (either CPX-351 or a combination called CLAG-M) can help medically less-fit adults with acute myeloid leukemia live longer and achieve remission. About 60 participants will receive one of the two treatments. The goal is t…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug targets genetic weakness in Hard-to-Treat blood cancers
Disease control CompletedThis study tests a drug called FT-2102 (olutasidenib) in people with acute myeloid leukemia or myelodysplastic syndrome whose cancers have a specific IDH1 gene mutation. The drug is given alone or combined with standard chemotherapy drugs (azacitidine or cytarabine). The goal is …
Phase: PHASE1, PHASE2 • Sponsor: Forma Therapeutics, Inc. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Immunotherapy blinatumomab shows promise in kids with relapsed leukemia
Disease control CompletedThis Phase 3 trial tested the drug blinatumomab in 111 children with high-risk relapsed B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is an immunotherapy that helps the body's immune cells attack cancer cells. The study compared blinatumomab to standard chemotherap…
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Could a pill keep AML at bay? new study tests maintenance therapy after chemo
Disease control CompletedThis study looked at whether taking oral azacitidine (Onureg) as maintenance therapy can help older adults with acute myeloid leukemia (AML) stay in remission longer after treatment with CPX-351 chemotherapy. The study included 100 patients aged 65 and older who had achieved remi…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Remote Check-Ups may be safe for heart patients after a heart attack
Disease control CompletedThis study looked at whether follow-up visits by phone or video are as safe as in-person visits for people who had a heart attack and received a stent. 88 patients were split into two groups: one had telemedicine check-ups at 1, 3, and 6 months, and the other had standard office …
Phase: NA • Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Balloon treatment aims to defuse 'Time Bomb' plaques in heart arteries
Disease control CompletedThis study tested whether a drug-coated balloon can stabilize fatty plaques in heart arteries that are at risk of rupturing and causing a heart attack. Researchers treated 45 patients with a recent heart condition, using a special balloon to deliver medication directly to the pla…
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Chemotherapy showdown: which combo works best for T-Cell cancers in kids?
Disease control CompletedThis large phase 3 trial studied nearly 1,900 children and young adults with newly diagnosed T-cell acute lymphoblastic leukemia or T-cell lymphoblastic lymphoma. Researchers compared different chemotherapy combinations, including varying doses of methotrexate and adding the drug…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Immunotherapy combo shows promise for Tough-to-Treat blood cancers
Disease control CompletedThis phase 2 trial tested the immunotherapy drug pembrolizumab (Keytruda) alone or combined with idelalisib or ibrutinib in 65 patients with chronic lymphocytic leukemia (CLL) or low-grade B-cell non-Hodgkin lymphoma (NHL) that had returned or stopped responding to treatment. The…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New drug cocktail shows promise for Tough-to-Treat leukemia in seniors
Disease control CompletedThis study tested a chemotherapy drug called CPX-351 in 59 adults aged 60 to 75 with a high-risk form of acute myeloid leukemia (AML). The goal was to see how well it could put the cancer into remission. Participants received the drug through an IV, and some also had a stem cell …
Phase: PHASE2 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Heart attack drug combo may unclog arteries when standard methods fail
Disease control CompletedThis completed trial tested whether giving epinephrine and verapamil directly into the heart arteries could help restore blood flow in heart attack patients whose vessels remain blocked despite standard treatment. 104 adults with ST-elevation heart attacks were enrolled. The stud…
Phase: NA • Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Targeted therapy combo aims to improve survival in older leukemia patients
Disease control CompletedThis study tests whether adding the targeted drug inotuzumab ozogamicin to a milder chemotherapy regimen improves survival in adults over 55 with a specific type of acute lymphoblastic leukemia (ALL) that is Philadelphia chromosome-negative and CD22-positive. Participants receive…
Phase: PHASE2 • Sponsor: Versailles Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Triple-Drug cocktail aims to boost remission in acute myeloid leukemia
Disease control CompletedThis phase 3 trial is testing whether a combination of three drugs—azacitidine, venetoclax, and ATRA—can safely and effectively treat adults newly diagnosed with acute myeloid leukemia (AML). The drugs work together to stop cancer cell growth by demethylating DNA, promoting cell …
Phase: PHASE3 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental pill targets Hard-to-Treat blood cancers
Disease control CompletedThis study tested a daily pill called E7820 in 12 adults with relapsed or treatment-resistant acute myeloid leukemia, myelodysplastic syndromes, or chronic myelomonocytic leukemia. All participants had specific mutations in splicing factor genes. The goal was to see if the drug c…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a cannabidiol drug help heal inflamed hearts?
Disease control CompletedThis trial tests whether CardiolRx, a pharmaceutical cannabidiol, can improve heart recovery in adults with acute myocarditis (heart muscle inflammation). Participants receive either CardiolRx or a placebo for 12 weeks. The study uses heart MRI scans to measure changes in heart t…
Phase: PHASE2 • Sponsor: Cardiol Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental drug RAD001 tested for tough leukemias and lymphomas
Disease control CompletedThis study tested the drug RAD001 (everolimus) in 29 patients with relapsed or hard-to-treat blood cancers like leukemia, lymphoma, and myelofibrosis. The goal was to find the safest highest dose and see if it helps control the disease. It was a small early-phase trial at a singl…
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Kidney alert team may cut deaths in hospital patients
Disease control CompletedThis study tested whether quickly alerting a kidney specialist team when hospitalized patients show signs of severe kidney disease could improve survival. Over 1,100 patients in France were included. The team of a nephrologist and pharmacist would help manage care during the hosp…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Baking soda treatment tested for ICU kidney patients
Disease control CompletedThis study tested whether giving sodium bicarbonate (a common substance that neutralizes acid) to critically ill patients with severe metabolic acidosis and moderate-to-severe acute kidney injury could improve survival at 90 days. The trial enrolled 640 adults in the ICU who had …
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could poison gas heal lungs? small trial tests carbon monoxide for ARDS
Disease control CompletedThis phase II trial tested whether inhaling low doses of carbon monoxide (200 ppm for 90 minutes daily for 3 days) is safe and helpful for people with acute respiratory distress syndrome (ARDS), a severe lung condition. Only 4 intubated adults participated, making this a very sma…
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could an Immune-Modulating drug slow early Alzheimer's?
Disease control CompletedThis phase 2 trial investigates whether lenalidomide, a drug that calms inflammation, can slow cognitive decline in people with mild cognitive impairment due to Alzheimer's disease. Participants take lenalidomide or a placebo for up to 12 months, followed by a 6-month washout per…
Phase: PHASE2 • Sponsor: St. Joseph's Hospital and Medical Center, Phoenix • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Real-World data suggests asciminib may help some leukemia patients
Disease control CompletedThis study reviewed medical records of 37 adults with Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) who took asciminib because other treatments stopped working or caused side effects. Researchers wanted to see how many patients achieved complete remission within th…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
New drug shows promise in controlling transplant complications
Disease control CompletedThis study tested a new drug called EQ001 in 30 people who developed acute graft-versus-host disease (aGVHD) after a stem cell transplant. aGVHD is a serious condition where donor immune cells attack the patient's body. The goal was to see if EQ001 is safe and can help control th…
Phase: PHASE1, PHASE2 • Sponsor: Biocon Limited • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New study tests safer sedation for tiny lungs
Disease control CompletedThis study looked at whether giving a sedative called propofol to very premature babies (under 32 weeks) before a less invasive breathing treatment (LISA) is safe and reduces the need for a breathing machine. The trial involved 233 infants with breathing problems. Researchers com…
Phase: PHASE3 • Sponsor: University Hospital, Grenoble • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New drug combo shows promise for tough leukemia cases
Disease control CompletedThis phase 2 trial tested a combination of two drugs, ibrutinib and blinatumomab, in 19 adults with B-cell acute lymphoblastic leukemia that had come back or wasn't responding to treatment. The goal was to see how many patients achieved complete remission. The study is completed,…
Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New liposome combo shows promise for Tough-to-Treat leukemia
Disease control CompletedThis study tested a new formulation of two chemotherapy drugs (CPX-351) in 56 adults with newly diagnosed acute myeloid leukemia (AML) who were at high risk of not responding to standard treatment. The goal was to find the best dose and see how well it worked to stop cancer cells…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Can a dialysis-like treatment save kids with lung failure after transplant?
Disease control CompletedThis study tested whether early hemofiltration, a continuous dialysis procedure, could improve survival in children who develop respiratory failure after a bone marrow transplant. Only 6 children took part. The idea was to filter out inflammatory molecules that drive lung damage.…
Phase: PHASE2, PHASE3 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New dialysis technique may help critically ill patients stay stable
Disease control CompletedThis study looked at 120 critically ill patients with acute kidney injury and shock who needed dialysis. Researchers compared a special method called sodium profiling dialysis to standard dialysis to see if it helped keep blood pressure stable and reduced fluid buildup in the lun…
Sponsor: Fayoum University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could a Gene-Targeting drug boost chemo for older leukemia patients?
Disease control CompletedThis study tested whether adding a drug called oblimersen to standard chemotherapy (daunorubicin and cytarabine) helps older adults (60+) with untreated acute myeloid leukemia live longer or achieve remission. About 500 participants were randomly assigned to receive chemo with or…
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Blood test could help kids avoid harmful steroid side effects after transplant
Disease control CompletedThis study tested whether a blood test (GVHD biomarkers) can help doctors safely reduce steroid doses in children with graft-versus-host disease (GVHD) after a bone marrow transplant. Fifty children with newly diagnosed GVHD received prednisone, and those with low biomarker level…
Phase: PHASE2 • Sponsor: John Levine • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
One cord blood unit may replace two in stem cell transplants for blood cancer
Disease control CompletedThis study tested a new way to treat blood cancers like leukemia in 16 adults who did not have a standard bone marrow donor. Doctors used a single unit of cord blood that was grown in a lab to increase the number of stem cells before transplant. The goal was to see if this method…
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Short-Term stronger blood thinner may cut heart risks in AF patients
Disease control CompletedThis study tested whether giving a more powerful antiplatelet drug (prasugrel or ticagrelor) for one month after a heart attack, along with a standard blood thinner, could reduce heart attacks, strokes, and deaths in people with atrial fibrillation. The 602 participants were then…
Phase: PHASE4 • Sponsor: Ludwig-Maximilians - University of Munich • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Intense Pre-Transplant combo shows promise for tough leukemias
Disease control CompletedThis phase 2 trial tested a combination of intravenous busulfan, etoposide, and low-dose total-body irradiation before a donor stem cell or bone marrow transplant in 30 patients with advanced leukemia or myelodysplastic syndromes. The goal was to see how well this regimen control…
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Selective immune cell removal may tame transplant complications
Disease control CompletedThis study tested whether removing a specific type of immune cell (naïve T cells) from donor stem cell grafts could prevent graft-versus-host disease (GVHD) after a stem cell transplant for blood cancers. The trial enrolled 84 patients who received high- or medium-intensity chemo…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New combo shows promise for High-Risk leukemia patients
Disease control CompletedThis study tested a new treatment for adults with a high-risk form of acute promyelocytic leukemia (APL). The experimental therapy combined arsenic trioxide, ATRA, and a low dose of idarubicin, aiming to improve survival and reduce side effects compared to the standard chemothera…
Phase: PHASE3 • Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Protein and exercise combo tested to fight muscle loss in sick kids
Disease control CompletedThis pilot study tested whether giving critically ill children on breathing machines extra protein along with a personalized exercise program could help preserve muscle mass and improve recovery. The trial enrolled 18 children in the ICU and measured how feasible and safe the app…
Phase: NA • Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can a biomarker predict who responds to a new AML combo?
Disease control CompletedThis phase 2 trial tested whether certain biomarkers in bone marrow can predict how well patients with high-risk acute myeloid leukemia (AML) respond to treatment with sirolimus plus standard chemotherapy (MEC). The study enrolled 39 adults with AML that was hard to treat or had …
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Massive trial seeks best chemo cocktail for kids with leukemia
Disease control CompletedThis large phase 3 trial enrolled over 9,000 children with newly diagnosed standard-risk B-ALL or localized B-LLy. Researchers tested different combinations and doses of chemotherapy drugs to see which worked best with the fewest side effects. The goal was to improve disease-free…
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New drug combo may make cord blood transplants safer for blood cancer patients
Disease control CompletedThis study tested whether adding the drug tocilizumab to standard care could reduce the risk of graft-versus-host disease (GVHD) after a cord blood transplant in adults with blood cancers. GVHD is a serious complication where donor cells attack the patient's body. Tocilizumab blo…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Could a single drug infusion limit permanent heart damage during a heart attack?
Disease control CompletedThis study tested whether a drug called dexrazoxane, given through a vein, can reduce permanent heart muscle damage in people having a severe heart attack (STEMI). Fifty adults received either the drug or a placebo during their standard stent procedure. The goal was to see if the…
Phase: PHASE2 • Sponsor: Rohan Dharmakumar • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Engineered immune cells take aim at tough childhood cancers
Disease control CompletedThis early-phase trial tested whether a new type of immune cell therapy (CD22 CAR T cells) could be safely made and given to 10 children and young adults whose B-cell leukemia or lymphoma had come back or stopped responding to treatment. The therapy uses the patient's own immune …
Phase: PHASE1 • Sponsor: Kara Lynn Davis • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Oxygen boost after heart attack shows promise in small study
Disease control CompletedThis study tested a new way to give extra oxygen to the heart after a heart attack. Twenty patients received a special oxygen treatment for one hour through a thin tube placed in the heart artery. The main goal was to see if the procedure was safe and could be done without proble…
Phase: NA • Sponsor: TherOx • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for AML patients: drug combo targets leukemia cells
Disease control CompletedThis study tested a new drug called S65487, which blocks a protein that helps leukemia cells survive, combined with the standard drug azacitidine. The trial included 57 adults with untreated acute myeloid leukemia who were not healthy enough for intensive chemotherapy. Researcher…
Phase: PHASE1, PHASE2 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
One pill to rule them all? polypill aims to boost heart drug adherence
Disease control CompletedThis completed Phase 2 trial tested whether a single daily polypill (containing a statin, aspirin, and a blood thinner) could improve medication adherence in 140 patients who had a heart attack and received a stent. The study compared the polypill to usual care with separate pill…
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Anesthesia choice may boost kidney transplant success
Disease control CompletedThis study tested whether using sevoflurane gas for anesthesia during kidney transplant surgery helps the new kidney recover faster than standard propofol anesthesia. 120 adults receiving a kidney transplant were randomly assigned to one of the two anesthetics. Researchers tracke…
Phase: PHASE3 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New hope for older AML patients: triple drug combo aims to control disease and prevent relapse
Disease control CompletedThis study tested a combination of three drugs (low-dose cytarabine or azacitidine, plus venetoclax and quizartinib) in 113 adults aged 60 and older with newly diagnosed acute myeloid leukemia (AML) who were not eligible for standard chemotherapy. The goal was to quickly control …
Phase: PHASE1, PHASE2 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Lifting weights to fight transplant After-Effects: a new hope for young survivors
Disease control CompletedThis study looked at whether a 16-week strength training program can prevent or reduce late effects like muscle loss, heart disease, and diabetes in adults who had a bone marrow transplant as children. 28 survivors and a matched control group participated. The goal was to see if …
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New monitoring technique may shield kidneys during liver surgery
Disease control CompletedThis study tested a new way to monitor kidney oxygen levels during liver surgery to try to prevent acute kidney injury (AKI). 80 adults having liver surgery were randomly assigned to either standard care or extra monitoring that triggered a step-by-step treatment plan if oxygen l…
Phase: PHASE1 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New anticoagulation strategy tested for dialysis circuits in ECMO patients
Disease control CompletedThis study tested whether adding regional citrate anticoagulation (RCA) to standard heparin can reduce clotting in continuous kidney dialysis circuits for patients on ECMO. Eighteen ICU adults with ARDS and acute kidney injury were enrolled. Each patient received alternating peri…
Phase: NA • Sponsor: University of Milano Bicocca • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New endoscopic procedure may offer better Long-Term relief for gallbladder patients too sick for surgery
Disease control CompletedThis study looked at 484 high-risk surgical patients with acute cholecystitis (gallbladder inflammation) who first received a standard drainage tube through the skin. Some then had a newer procedure using an endoscope to place a metal stent inside the gallbladder. Researchers com…
Sponsor: University of Bologna • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New blood filter may boost survival in septic shock patients on dialysis
Disease control CompletedThis study looked back at 400 critically ill patients with septic shock and kidney failure who needed dialysis. Researchers compared those who received a special filter (Oxiris) that removes toxins and inflammation-causing substances to those who got standard filters. The goal wa…
Sponsor: Clinica Universidad de Navarra, Universidad de Navarra • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Pill may replace shots for blood cancer patients, study finds
Disease control CompletedThis study tested whether an oral medication (CC-486) could help elderly patients with a serious blood disorder called myelodysplastic syndrome (MDS) maintain their improvement after initial injectable treatment. Eleven patients who had responded to injectable azacitidine switche…
Phase: PHASE2 • Sponsor: University of Florence • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for tough blood cancers? early trial tests LYT-200
Disease control CompletedThis early-stage study tested a new drug called LYT-200 in 101 adults whose acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) had come back or stopped responding to treatment. The main goals were to check the drug's safety and find the right dose. While not…
Phase: PHASE1 • Sponsor: PureTech • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug shows promise for ARDS patients in major trial
Disease control CompletedThis clinical trial tested a drug called sivelestat sodium in 324 adults with acute respiratory distress syndrome (ARDS) and systemic inflammation. The drug aims to block a harmful enzyme that damages lung tissue. Researchers measured whether it improved oxygen levels and reduced…
Phase: PHASE4 • Sponsor: Sichuan Provincial People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New combo attack on lymphoma shows promise in early trial
Disease control CompletedThis early-phase trial tested a three-part treatment for non-Hodgkin lymphoma: freezing tumors (cryoablation), injecting a personalized dendritic cell vaccine made from the patient's own cells, and giving the immunotherapy drug pembrolizumab (Keytruda). The goal was to find the s…
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug cocktail aims to cut bleeding and heart attacks in atrial fibrillation patients
Disease control CompletedThis study tested a combination of two drugs, rivaroxaban and ticagrelor, in 40 patients with atrial fibrillation who had a stent placed. The goal was to see if this combo causes less bleeding and prevents heart attacks or strokes better than current treatments. Patients took the…
Phase: PHASE3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Can a gout drug cool down artery inflammation in diabetics?
Disease control CompletedThis study tested whether colchicine, a drug used for gout, can reduce inflammation in the arteries of people with diabetes who recently had a heart attack or stroke. Researchers used a special PET scan to measure inflammation in the blood vessels. 115 participants were randomly …
Phase: PHASE3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New study checks bleeding risk when CLL drug meets blood thinners
Disease control CompletedThis study observed 45 people with chronic lymphocytic leukemia (CLL) who were taking the drug acalabrutinib (Calquence) along with a direct oral anticoagulant (DOAC), a type of blood thinner. The main goal was to see how many patients had serious bleeding events while on this co…
Sponsor: iOMEDICO AG • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Experimental cell treatment shows promise for COVID-19 lung failure
Disease control CompletedThis early-stage study tested a single dose of mesenchymal stromal cells in 7 COVID-19 patients with severe acute respiratory distress syndrome (ARDS) who were on ventilators. The main goal was to check safety, looking for serious side effects like heart problems or blood clots w…
Phase: PHASE1 • Sponsor: Uppsala University • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Stem cell transplant study seeks best way to prevent immune attack
Disease control CompletedThis study tested different drug combinations to prevent graft-versus-host disease (GVHD) in 174 people with blood cancers receiving stem cells from an unrelated donor. GVHD is a serious side effect where donor cells attack the patient's body. The goal was to find which drug regi…
Phase: PHASE3 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New drug aims to heal hearts after attack – trial results awaited
Disease control CompletedThis study tested a new medicine called CDR132L in 294 people who had a recent heart attack and had weak heart pumping (ejection fraction 45% or less). Participants received one of two doses of CDR132L or a placebo, added to standard care, for 6 months. The goal was to see if the…
Phase: PHASE2 • Sponsor: Cardior Pharmaceuticals GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New breathing tech aims to free ICU patients from ventilators faster
Disease control CompletedThis study tested whether a newer breathing support method called NAVA helps patients with ARDS come off mechanical ventilation faster than standard PSV. 130 tracheotomy patients were randomly assigned to one of the two methods. The main goal was to see how many days patients wer…
Phase: NA • Sponsor: Southeast University, China • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Heart study tests Lower-Dose blood thinner and new stents for better safety
Disease control CompletedThis study looked at over 3,400 people with acute coronary syndrome (a heart attack or unstable angina) who received a stent to open blocked arteries. Researchers compared two types of stents (biostable vs. biodegradable polymer) and two doses of the blood thinner prasugrel (5 mg…
Phase: PHASE4 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New hope for young leukemia patients: combination chemo shows promise
Disease control CompletedThis study tested a combination of chemotherapy drugs in 318 adolescents and young adults (ages not specified but typically 15-39) with newly diagnosed acute lymphoblastic leukemia (ALL). The goal was to see how well the treatment worked at killing cancer cells and stopping the d…
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New drug duo shows promise for rare blood cancer
Disease control CompletedThis completed phase 2 study tested a combination of two drugs, isatuximab and cemiplimab, in 37 adults with relapsed or refractory NK/T-cell lymphoma, a rare and aggressive blood cancer. The goal was to see if the combination could shrink tumors or stop the cancer from growing. …
Phase: PHASE2 • Sponsor: Won Seog Kim • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Potassium binder lets heart patients get full drug benefits
Disease control CompletedThis study tested whether a drug called Lokelma (SZC) can help people with both chronic kidney disease and heart failure safely reach higher doses of life-saving heart medications (RAAS inhibitors) without dangerous potassium spikes. 112 adults with stable kidney disease and hear…
Phase: PHASE3 • Sponsor: St George's, University of London • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New study combines addiction treatment and IV antibiotics outside the hospital
Disease control CompletedThis study tested whether people with opioid use disorder and severe injection-related infections can be safely treated at home with antibiotics and buprenorphine (a medication for opioid use disorder). 71 participants were enrolled. The goal was to see if this integrated approac…
Phase: PHASE2 • Sponsor: Laura Fanucchi • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New combo aims to tame hairy cell leukemia with fewer side effects
Disease control CompletedThis study tested a combination of two drugs—vemurafenib (taken by mouth) and rituximab (given by IV)—in 15 people with hairy cell leukemia, a rare blood cancer. The goal was to see if this treatment works as well as or better than standard chemotherapy, but with fewer side effec…
Phase: PHASE2 • Sponsor: Scripps Health • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Cheap diabetes drug metformin slashes long COVID risk in major trial
Disease control CompletedThis study tested whether three common drugs—metformin, ivermectin, and fluvoxamine—could prevent severe illness and long COVID in 1,323 adults with early COVID-19. Participants were overweight or obese and not hospitalized. The key finding was that metformin reduced the risk of …
Phase: PHASE3 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for kids with hard-to-treat leukemia: experimental combo shows promise
Disease control CompletedThis study tested a new combination of chemotherapy drugs for children and young adults with acute lymphoblastic leukemia (ALL) that had returned or not responded to first treatment. The goal was to find the safest dose of clofarabine when given with other medicines. Twenty parti…
Phase: PHASE1 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can CT scans guide better breathing support for ARDS patients?
Disease control CompletedThis study tested whether using lung CT images to guide ventilator settings could reduce deaths in people with ARDS. 420 adults were assigned to either standard ventilator care or a strategy based on their lung morphology. The goal was to see if personalized ventilation could imp…
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Promising drug combo targets tough leukemia in early trial
Disease control CompletedThis early-phase study tested a two-drug combination (pevonedistat plus decitabine) in 12 people with high-risk acute myeloid leukemia (AML), including those who had relapsed or couldn't tolerate standard chemo. The main goal was to find the safest dose and identify side effects.…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a common anesthetic gas help ARDS patients breathe easier?
Disease control CompletedThis study tested whether inhaling sevoflurane, a gas usually used for anesthesia, for the first 48 hours could improve oxygen levels and reduce inflammation in 50 adults with moderate to severe ARDS. Participants were randomly assigned to receive either sevoflurane or a standard…
Phase: PHASE4 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a cancer drug fix an irregular heartbeat?
Disease control CompletedThis study looked at whether Vidaza, a drug used for acute leukemia, could also help treat atrial fibrillation (an irregular heartbeat). The idea was that Vidaza might reverse certain DNA changes that lower the activity of a gene important for heart function. Only one person took…
Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a common anesthetic help ARDS patients breathe easier?
Disease control CompletedThis study tested whether using sevoflurane (an inhaled anesthetic) for sedation could lower death rates and shorten time on a ventilator in patients with acute respiratory distress syndrome (ARDS). 700 adults were randomly assigned to receive either sevoflurane or standard propo…
Phase: PHASE3 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Old drug, new hope: enasidenib may ease anemia in blood cancer patients
Disease control CompletedThis early-phase trial tested the drug enasidenib in 17 people with low-risk myelodysplastic syndrome or a related leukemia who had anemia and did not have a specific gene mutation. The goal was to see if the drug could safely improve red blood cell counts and reduce the need for…
Phase: PHASE1, PHASE2 • Sponsor: Tian Yi Zhang • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New drug combo tested for tough childhood leukemia
Disease control CompletedThis early-phase study tested whether adding the targeted drug palbociclib to standard chemotherapy is safe for children with acute lymphoblastic leukemia that has returned or not responded to treatment. Only 2 children took part, and the main goal was to find the highest tolerab…
Phase: PHASE1 • Sponsor: Tanja Andrea Gruber • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Blue dye may keep blood pressure up during kidney dialysis
Disease control CompletedThis study tested whether methylene blue, a dye that affects blood vessel function, can prevent dangerous drops in blood pressure during kidney dialysis. It involved 261 critically ill adults with acute kidney injury who needed dialysis. The goal was to see if the treatment could…
Phase: PHASE2 • Sponsor: Federal University of São Paulo • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New Two-Step transplant shows promise for blood cancer patients
Disease control CompletedThis study tested a two-step stem cell transplant for people with blood cancers like leukemia and lymphoma. First, patients received low-dose chemotherapy and radiation to prepare their bodies. Then, they got donor stem cells followed by drugs to prevent the donor cells from atta…
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New eyedrop shows promise for pink eye in small trial
Disease control CompletedThis study tested a new anti-infective eyedrop called SCH1 in 30 adults with acute infectious conjunctivitis (pink eye). Participants received either the active eyedrop or a placebo. The goal was to see if the drug could completely clear redness and discharge. The trial is comple…
Phase: PHASE2 • Sponsor: Sacsh • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Common antibiotic could shield hearts after attack
Disease control CompletedThis study tested whether a short course of doxycycline, a common antibiotic, can prevent heart damage after a heart attack. 174 adults who had a severe heart attack received either doxycycline or a placebo twice daily for one week. Researchers then used MRI scans to check heart …
Phase: PHASE2 • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New drug shows promise in leukemia battle
Disease control CompletedThis study tested a new drug, crenolanib, against the standard drug midostaurin in adults with a specific genetic type of acute myeloid leukemia (FLT3-mutated AML). All 214 participants received standard chemotherapy and, if eligible, a bone marrow transplant, plus one of the two…
Phase: PHASE3 • Sponsor: Arog Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New drug combo aims to prevent leukemia return after remission
Disease control CompletedThis study tested whether a combination of two drugs, venetoclax and azacitidine, can help adults with acute myeloid leukemia (AML) stay in remission after initial chemotherapy. The goal was to find the right dose and see if it safely delays the cancer from coming back. The study…
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
One-Time artery fix may cut hospital time for heart attack patients
Disease control CompletedThis study looked at two ways to treat heart attack patients who have multiple blocked arteries. One group had all blockages fixed in a single procedure, while the other group had the main blockage fixed first and the others in a separate procedure later. The goal was to see if t…
Phase: NA • Sponsor: Tanta University • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New hope for elderly leukemia patients: drug combo shows promise
Disease control CompletedThis study tested a combination of two drugs, azacitidine and venetoclax, in 42 elderly patients (age 60+) with newly diagnosed acute myeloid leukemia (AML) who could not have standard chemotherapy. The treatment was given as an initial 'induction' phase, followed by a 'maintenan…
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Promising combo targets Leukemia's genetic weakness
Disease control CompletedThis study tested whether adding the drug crenolanib to standard chemotherapy helps adults up to age 75 with a hard-to-treat form of acute myeloid leukemia (AML) that has a specific genetic change (FLT3 mutation). Participants received either crenolanib or a placebo alongside che…
Phase: PHASE3 • Sponsor: Arog Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Personalized plans boost survival odds for older stem cell patients
Disease control CompletedThis study tested a personalized geriatric optimization plan (GO!) in 30 adults aged 60 and older who were getting a donor stem cell transplant for blood cancers or bone marrow failure. The plan included tailored advice on diet, sleep, activity, and medications to improve physica…
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New cocktail aims to tackle tough myeloma cases
Disease control CompletedThis study tested a combination of thalidomide, bortezomib, and high-dose melphalan followed by a stem cell transplant in 29 patients with advanced multiple myeloma who had already failed one round of treatment. The goal was to find the safest dose of thalidomide and see how well…
Phase: PHASE1, PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New targeted therapy shows promise for Tough-to-Treat leukemia
Disease control CompletedThis study tested a drug called GO-203-2C, which targets a protein (MUC1) found on cancer cells while sparing healthy cells. It was given alone or with another drug (decitabine) to 33 adults with acute myeloid leukemia that had returned or not responded to treatment. The main goa…
Phase: PHASE1, PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New combo therapy may boost heart recovery after attack
Disease control CompletedThis study looked at 128 heart attack patients who had a procedure to open blocked arteries. Some patients received an extra blood thinner called cangrelor on top of standard ticagrelor. The goal was to see if the combination improved blood flow to the heart and reduced leftover …
Phase: PHASE4 • Sponsor: University Hospital, Caen • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Engineered immune cells take on tough blood cancers in early trial
Disease control CompletedThis study tested a new treatment called CTX131 for adults with certain blood cancers (T-cell lymphoma, B-cell lymphoma, or acute myeloid leukemia) that had returned or stopped responding to standard therapy. CTX131 uses a patient's own immune cells, modified with CRISPR gene edi…
Phase: PHASE1, PHASE2 • Sponsor: CRISPR Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New hope for HIV patients with rare brain disease?
Disease control CompletedThis study tested whether adding a powerful HIV drug called FUZEON® to standard antiretroviral therapy could help people with HIV who also have a rare brain infection called PML. PML is caused by a virus that attacks the brain when the immune system is weak. The goal was to see i…
Phase: PHASE2 • Sponsor: French National Agency for Research on AIDS and Viral Hepatitis • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Stem cell hope for leukemia patients
Disease control CompletedThis study looked at whether a stem cell transplant can help people under 65 with untreated chronic lymphocytic leukemia (CLL) live longer without their cancer getting worse. 241 participants received either standard treatment or a transplant. The main goal was to see how long th…
Phase: PHASE3 • Sponsor: University Hospital, Caen • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New cocktail aims to wipe out CLL early
Disease control CompletedThis phase 2 trial tested a combination of chemotherapy (FCR) plus the drug lenalidomide in 21 people with previously untreated chronic lymphocytic leukemia (CLL). The goal was to see if adding lenalidomide could help more patients achieve a complete response, meaning no signs of…
Phase: PHASE2 • Sponsor: Hackensack Meridian Health • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Could a simple gas help ventilated COVID-19 patients breathe easier?
Disease control CompletedThis study tested whether breathing in nitric oxide gas can improve oxygen levels in severely ill COVID-19 patients who are on ventilators. Researchers enrolled 200 adults in the ICU with confirmed COVID-19 and severe breathing problems. Patients received either standard care plu…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New drug combo aims to tame deadly transplant complication
Disease control CompletedThis phase II trial tested whether adding the drug itacitinib to standard medications (tacrolimus and sirolimus) can better prevent graft-versus-host disease (GVHD) in 59 patients with blood cancers receiving donor stem cell transplants. GVHD occurs when donor immune cells attack…
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Engineered immune cells take aim at tough blood cancers
Disease control CompletedThis study tested whether a new type of immune cell therapy, called CD22 CAR T cells, could be made from patients' own blood cells and safely given to adults with hard-to-treat B-cell leukemia or lymphoma. The main goals were to see if the cells could be produced successfully and…
Phase: PHASE1 • Sponsor: Matthew Frank • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New drug shows promise for dangerous pancreatitis complication
Disease control CompletedThis study tested an experimental drug called CM4620-IE in 21 people with severe pancreatitis that caused body-wide inflammation (SIRS). The goal was to see if the drug is safe and to find the best dose for future studies. Participants received the drug plus standard care or stan…
Phase: PHASE2 • Sponsor: CalciMedica, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Steroid shot before angioplasty may limit heart damage
Disease control CompletedThis study tested whether giving a single, strong dose of steroids to people right after a major heart attack (STEMI) could reduce the amount of heart muscle that gets permanently damaged. The steroid was given before the standard emergency procedure to open the blocked artery. T…
Phase: PHASE2 • Sponsor: Thomas Engstrom • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Expanded cord blood transplant shows early promise for young cancer patients
Disease control CompletedThis study tested a new method of cord blood transplantation in 13 children and young adults with high-risk myeloid cancers. The approach uses a molecule called UM171 to grow more stem cells from a single cord blood unit, aiming to speed up recovery and reduce complications. Earl…
Phase: PHASE1, PHASE2 • Sponsor: ExCellThera inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New radiation combo aims to boost stem cell transplant success in tough leukemia cases
Disease control CompletedThis study tested a new way to prepare patients with relapsed or hard-to-treat acute leukemia for a donor stem cell transplant. It combined a precise form of radiation therapy (IMRT) with two chemotherapy drugs (etoposide and cyclophosphamide) before the transplant. The goal was …
Phase: PHASE1, PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New radiation technique aims to make stem cell transplants safer for leukemia patients
Disease control CompletedThis study tested a new way to give radiation before a stem cell transplant for people aged 16 to 45 with acute lymphoblastic leukemia (ALL). The goal was to see if targeting radiation only to the bone marrow and lymph nodes (called TMLI) is safe and works as well as full-body ra…
Phase: NA • Sponsor: Hospital Universitario Dr. Jose E. Gonzalez • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Cord blood boost: new technique shows promise for tough leukemia cases
Disease control CompletedThis study tested a new way to prepare cord blood for transplant in 30 people with high-risk leukemia or myelodysplasia. The cord blood was treated with a molecule called UM171 to help it grow more stem cells. The goal was to see if this approach is safe and helps patients recove…
Phase: PHASE2 • Sponsor: ExCellThera inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could one drug replace two after a heart attack stent?
Disease control CompletedThis study looked at whether using only ticagrelor (a blood thinner) after heart attack stenting is safe, instead of the usual two-drug combination. It included 200 adults who had a stent placed during a heart attack. The main goal was to check for serious heart problems or stent…
Phase: PHASE2 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
No-Surgery gallbladder fix shows promise in small trial
Disease control CompletedThis study tested a procedure called EUS-guided gallbladder drainage (EGBD) as an alternative to gallbladder removal surgery for 30 adults with acute cholecystitis (gallbladder inflammation). The goal was to see if it could safely resolve symptoms like fever and pain without need…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New Two-Step transplant shows promise for tough blood cancers
Disease control CompletedThis phase 2 trial tested a two-step stem cell transplant approach for 47 patients with high-risk blood cancers like leukemia and lymphoma. The method uses the drug cyclophosphamide to lower the chance of graft-versus-host disease (GVHD), a common complication. The goal was to se…
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Could stem cells help COVID-19 patients breathe easier?
Disease control CompletedThis study tested whether a single dose of stem cells (mesenchymal stromal cells) could help patients with severe COVID-19 lung inflammation breathe better. Twenty adults with confirmed COVID-19 and acute respiratory distress syndrome were randomly assigned to receive either the …
Phase: PHASE2 • Sponsor: Cristina Avendaño Solá • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New breathing machine method aims to shield heart in lung failure patients
Disease control CompletedThis completed study tested a breathing machine strategy that uses lung pressure measurements to guide settings, aiming to protect the right side of the heart in patients with acute respiratory distress syndrome (ARDS). Forty adults on ventilators for less than 72 hours were incl…
Phase: NA • Sponsor: Beijing Chao Yang Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Stem cell injection aims to repair hearts after major attack
Disease control CompletedThis study tested a new treatment for people who had a severe heart attack and still have weak heart pumping. Doctors took the patients' own blood stem cells, grew more of them in a special machine, and injected them into the heart. The goal was to see if this could improve heart…
Phase: PHASE2 • Sponsor: CellProthera • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Last-resort leukemia combo shows early promise in tiny trial
Disease control CompletedThis early-phase study tested a combination of two drugs, venetoclax and omacetaxine, in 6 adults with acute myeloid leukemia (AML) whose cancer had stopped responding to venetoclax-based treatments. The main goal was to find the safest dose of omacetaxine when given with venetoc…
Phase: PHASE1 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New combo shows promise for tough lymphomas
Disease control CompletedThis study tested adding lenalidomide to a standard chemotherapy regimen (EPOCH-R) in 55 people with aggressive B-cell lymphomas linked to the MYC gene. The goal was to find the best dose and see if the combination improves how long patients live without their cancer getting wors…
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Microtransplant without immune drugs shows promise for leukemia patients too sick for standard transplant
Disease control CompletedThis early-phase trial tested a new type of stem cell transplant called a microtransplant in 25 people with myeloid blood cancers (like leukemia) who were too old or frail for a standard transplant. Unlike a regular transplant, this one used stem cells from a partially matched fa…
Phase: PHASE1 • Sponsor: Institut Paoli-Calmettes • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Stem cell infusion shows promise for heart attack recovery
Disease control CompletedThis study tested a single intravenous infusion of stem cells (PROCHYMAL) in 220 adults who had their first heart attack within the prior week. The goal was to see if the treatment could safely improve heart function, as measured by MRI scans at 3 months. Participants were random…
Phase: PHASE2 • Sponsor: Mesoblast, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New stent method may cut risks and radiation for heart patients
Disease control CompletedThis study tested a new, simpler method called JINS for placing drug-coated stents in heart arteries. Researchers wanted to see if it could help achieve better stent placement while reducing extra radiation and complications from balloon inflation. The study involved 161 people w…
Phase: NA • Sponsor: Zunyi Medical College • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug combo shows promise for Hard-to-Treat bone marrow disease
Disease control CompletedThis early-phase trial tested a combination of two drugs, ibrutinib and lenalidomide, in 4 patients with myelodysplastic syndrome (MDS) who had not responded to or could not tolerate standard treatments. The main goal was to find the safest dose and identify side effects. While t…
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Which drug wins? trial pits terlipressin against octreotide for kidney crisis
Disease control CompletedThis study compares two medicines, terlipressin and octreotide, for treating hepatorenal syndrome—a serious kidney complication of advanced liver disease. Sixty adults aged 30 to 70 will receive one of the drugs, and doctors will check kidney function after 48 hours to see which …
Phase: NA • Sponsor: Lahore General Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
One donor, two transplants: could this end lifelong Anti-Rejection drugs?
Disease control CompletedThis pilot study tested a combined bone marrow and kidney transplant from a partially matched family donor in 10 people with both a blood disorder and chronic kidney disease. The goal was to treat both conditions at once and possibly reduce the need for lifelong anti-rejection dr…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Breast milk mouth care may help preterm infants breathe easier
Disease control CompletedThis study tested whether giving oral care with maternal breast milk every 3 hours to preterm babies on breathing machines could improve outcomes. 70 infants born before 34 weeks were included. Researchers measured how long babies needed ventilation, hospital stay length, and rat…
Phase: NA • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Heart attack patients: can a common gout pill improve bypass recovery?
Disease control CompletedThis study tested whether the anti-inflammatory drug colchicine can reduce complications like irregular heartbeat, heart sac inflammation, and heart damage after coronary artery bypass surgery. 100 patients who had a recent heart attack and needed bypass surgery were randomly ass…
Phase: PHASE2 • Sponsor: University of Sao Paulo General Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New vaccine combo targets Hard-to-Treat blood cancers
Disease control CompletedThis early-phase trial tested a cancer vaccine (CDX-1401) along with an immune booster, chemotherapy, and an immunotherapy drug in 8 people with myelodysplastic syndrome (MDS) or low-blast acute myeloid leukemia (AML). The goal was to see if the combination is safe and helps the …
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Leukemia drug shows promise in french compassionate use study
Disease control CompletedThis study looked at how well blinatumomab works and how safe it is in 92 adults with B-cell acute lymphoblastic leukemia that had come back or was not responding to treatment. Patients received the drug through a French compassionate use program. Researchers measured survival, r…
Sponsor: Group for Research in Adult Acute Lymphoblastic Leukemia • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Heart stent passes Real-World test: orsiro keeps arteries open
Disease control CompletedThis study looked at 556 people with coronary artery disease to confirm that the Orsiro drug-eluting stent is safe and effective in everyday use. The stent releases sirolimus to prevent artery re-narrowing. Researchers tracked how many patients had heart-related death, heart atta…
Sponsor: Biotronik, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
A glowing clue: light sensor may spot kidney damage in newborns
Diagnosis CompletedThis study tests whether a non-invasive light-based monitor, called near-infrared spectroscopy (NIRS), can detect kidney injury early in newborns with hypoxic-ischemic encephalopathy (HIE) who are undergoing cooling therapy. The monitor measures oxygen levels in the kidneys and b…
Sponsor: Agah Bahadır Öztürk,MD • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC
-
AI software may replace invasive heart tests — a validation study puts it to the test
Diagnosis CompletedThis study tests whether a software tool called AutocathFFR can accurately measure the severity of coronary artery blockages from standard 2D angiogram images, compared to the gold-standard invasive FFR measurement. The software uses machine learning to analyze images taken durin…
Sponsor: Medhub Ltd. • Aim: Diagnosis
Last updated Aug 15, 2026 00:00 UTC
-
Heart attack diagnosis gets a Sex-Specific upgrade: new study could save Women's lives
Diagnosis CompletedThis study looked at whether using different blood test cutoffs for men and women can better diagnose heart attacks. Current tests use the same cutoff for both sexes, which may miss heart attacks in women and over-diagnose them in men. Researchers tested new sex-specific cutoffs …
Phase: NA • Sponsor: Herlev Hospital • Aim: Diagnosis
Last updated Aug 14, 2026 00:00 UTC
-
Smart baby gym could predict motor delays before they start
Diagnosis CompletedThis study is testing a new way to detect motor delays in infants using a special play mat with sensors and a smart toy. Researchers will watch how babies move and interact with the toy, then use AI to spot early signs of disability. The goal is to create an easy, objective tool …
Sponsor: University of Pennsylvania • Aim: Diagnosis
Last updated Aug 12, 2026 00:00 UTC
-
AI on a simple ECG: a new way to gauge heart attack severity?
Diagnosis CompletedThis study tests whether artificial intelligence can read a standard ECG to predict how much heart muscle is damaged after a heart attack. Researchers will compare AI-ECG results with MRI images, the current gold standard, in 461 patients who had a heart attack and underwent a pr…
Sponsor: Yonsei University • Aim: Diagnosis
Last updated Aug 09, 2026 00:00 UTC
-
One blood test to rule out heart attacks?
Diagnosis CompletedThis study is testing whether measuring a protein called copeptin in the blood, alongside the standard troponin test, can help doctors quickly rule out a heart attack in people arriving at the emergency room with chest pain. Participants with chest pain that started within the la…
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Diagnosis
Last updated Aug 08, 2026 00:03 UTC
-
Ultrasound clue could flag which ICU patients need dialysis
Diagnosis CompletedThis study tests whether a non-invasive ultrasound measurement called the renal resistive index (RRI) can predict if acute kidney injury (AKI) will progress to a severe stage in intensive care unit (ICU) patients. Researchers will measure RRI in 120 adults with early-stage AKI wi…
Sponsor: Gulhane Training and Research Hospital • Aim: Diagnosis
Last updated Aug 07, 2026 00:00 UTC
-
Simple furosemide test may predict kidney decline in ICU
Diagnosis CompletedThis study tests whether a furosemide stress test can predict if acute kidney injury will get worse in ICU patients. Researchers will give furosemide to 140 patients and measure urine output over 2 hours. The goal is to see if the test can identify who will need dialysis, helping…
Phase: NA • Sponsor: Gulhane Training and Research Hospital • Aim: Diagnosis
Last updated Aug 07, 2026 00:00 UTC
-
A sharper eye on the heart: new blood test aims to spot heart attacks faster
Diagnosis CompletedThis trial evaluates a new high-sensitivity blood test (Mindray hs-cTnI) for diagnosing heart attacks in people arriving at the emergency room with symptoms like chest pain. Researchers will compare the test's accuracy against an existing approved test, using blood samples taken …
Sponsor: Fred Apple • Aim: Diagnosis
Last updated Jul 30, 2026 00:00 UTC
-
Urine test after a single dose of furosemide may spot kidney danger in ICU patients
Diagnosis CompletedThis study tests whether a quick urine measurement after a single dose of furosemide (a water pill) can predict which ICU patients with low albumin levels will develop severe acute kidney injury. Researchers will compare this test to blood biomarkers to see which is more accurate…
Phase: NA • Sponsor: Maithe Caroline Inacio • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
New One-Hour blood test could speed up heart attack diagnosis
Diagnosis CompletedThis study tested a new one-hour diagnostic algorithm using a protein called FABP to quickly confirm or rule out a type of heart attack called NSTEMI. It involved 20 male patients who arrived at the hospital within 4 hours of chest pain. The goal was to see if measuring FABP leve…
Phase: NA • Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Diagnosis
Last updated Jun 28, 2026 00:00 UTC
-
Tiny camera inside the gut could spot transplant complication faster
Diagnosis CompletedThis pilot study tested a special microscope-like camera (endocytoscopy) to diagnose upper gut graft-versus-host disease (aGVHD) in 14 patients who had a stem cell transplant. The camera was used during a standard endoscopy to see cells in real time. The goal was to see if this t…
Sponsor: Ruijin Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 14:03 UTC
-
Urine test may predict kidney recovery in septic shock patients
Diagnosis CompletedThis study tested whether a urine test measuring two proteins (TIMP2 and IGFBP7) can tell which septic shock patients will recover normal kidney function within 72 hours. Researchers analyzed data from 77 patients in French ICUs. The goal is to help doctors decide who needs aggre…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
Ultrasound may reveal hidden causes of ventilator weaning failure
Diagnosis CompletedThis study explores whether ultrasound can identify the reasons some patients fail to come off a mechanical ventilator. Researchers will scan the heart, lungs, and diaphragm of adults who have been on a ventilator for at least 24 hours and have not passed a spontaneous breathing …
Sponsor: University Health Network, Toronto • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
New device may predict kidney recovery in ICU patients
Diagnosis CompletedThis study tested whether the Nephrocheck™ device can predict if early acute kidney injury will reverse within 72 hours in patients with septic shock. Researchers enrolled 184 adults in the ICU and measured the device's accuracy. The goal is to help doctors decide who might recov…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
AI-Powered Low-Radiation CT scans could transform emergency diagnosis
Diagnosis CompletedThis study tested whether a low-dose CT scan, enhanced with deep learning image reconstruction, can diagnose acute abdominal conditions as accurately as a standard CT scan. 246 adults with abdominal pain received both scans, and the low-dose version used less than 30% of the usua…
Sponsor: Oslo University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
New PET tracer aims to spot hidden cancers without biopsy
Diagnosis CompletedThis completed early-phase study tested a new radioactive tracer called 18F-BL40 for PET/CT scans in 10 adults with certain blood cancers (like lymphoma and leukemia). The goal was to see if it safely and accurately detects tumors by targeting a receptor common in many cancers. R…
Sponsor: British Columbia Cancer Agency • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
New scan may spot hidden heart infections
Diagnosis CompletedThis study tested whether a special PET-CT scan using a radioactive tracer (18F-FDG) can improve diagnosis of infectious endocarditis on natural heart valves. Researchers scanned 31 adults with suspected endocarditis within 5 days of starting care. The goal was to see how well th…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Diagnosis
Last updated Jun 27, 2026 13:01 UTC
-
Simple ultrasound test may spot kidney risk in preeclampsia patients
Diagnosis CompletedThis study tested whether a special ultrasound score (called VEXUS) can predict acute kidney injury in women with severe preeclampsia when they are admitted to the hospital. Researchers examined 70 women using Doppler ultrasound to check blood flow in key veins. The goal was to s…
Sponsor: Cairo University • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
New ultrasound could spot heart trouble before It's too late for chemo patients
Diagnosis CompletedThis study tested whether a special heart ultrasound (2D strain imaging) can detect early signs of heart damage caused by anthracycline chemotherapy in 100 leukemia patients. The goal is to catch problems sooner, so doctors can adjust treatment and reduce the risk of permanent he…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Diagnosis
Last updated Jun 27, 2026 12:39 UTC
-
Light sensor may spot kidney danger during heart surgery
Diagnosis CompletedThis study looked at whether a special light-based monitor (near-infrared spectroscopy) placed on the skin can help predict kidney injury after heart surgery. Researchers measured oxygen levels in the kidneys of 113 adults during surgery and checked if low levels were linked to l…
Sponsor: SERAY TÜRKMEN • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
Blood test may spot deadly transplant complication earlier
Diagnosis CompletedThis completed study looked at whether certain proteins in the blood (called biomarkers) can help predict acute graft-versus-host disease (aGVHD) in 500 patients who had a stem cell transplant for blood cancers. Researchers measured levels of REG3, ST2, IL-6, IL-8, and TNF R ever…
Sponsor: Chinese PLA General Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:28 UTC
-
Heart attack patients under 60 get genetic screening for hidden cholesterol disorder
Diagnosis CompletedThis study tested whether offering genetic screening to younger heart attack patients (under 60) can uncover hidden cases of Familial Hypercholesterolemia (FH), an inherited condition causing very high cholesterol. Researchers recruited 140 patients admitted with a heart attack a…
Phase: NA • Sponsor: University of British Columbia • Aim: Diagnosis
Last updated Jun 27, 2026 12:28 UTC
-
ER heart scan may catch attacks earlier
Diagnosis CompletedThis study tested whether a simple bedside heart ultrasound measurement, called the S' wave, can help emergency doctors quickly identify acute coronary syndrome (heart attack or unstable angina) in patients with chest pain. Researchers enrolled 66 adults who came to the ER with c…
Phase: NA • Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain • Aim: Diagnosis
Last updated Jun 27, 2026 12:24 UTC
-
New imaging agent could sharpen detection of blood cancers
Diagnosis CompletedThis early-phase study tested a new radioactive tracer called [18F]-Fludarabine for PET scans in 10 people with untreated chronic lymphocytic leukemia or diffuse large B-cell lymphoma. The goal was to see how the tracer spreads in the body and how well it highlights cancer cells.…
Phase: PHASE1 • Sponsor: University Hospital, Caen • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
New ultrasound technique may predict lung problems in preterm infants
Diagnosis CompletedThis study looked at whether a special ultrasound technique called fetal lung elastography can predict respiratory distress syndrome (RDS) in preterm babies. Researchers measured lung stiffness in 80 unborn babies between 24-33 weeks of pregnancy and compared those who later deve…
Sponsor: Ankara Etlik City Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC
-
Could a common amino acid shield kidneys after heart surgery?
Prevention CompletedThis study looks at whether giving L-Arginine soon after heart surgery that uses a heart-lung machine can lower the chance of acute kidney injury. It will follow over 5,000 adults in the intensive care unit after their operation. The goal is to see if this simple amino acid might…
Sponsor: Xijing Hospital • Aim: Prevention
Last updated Aug 07, 2026 00:00 UTC
-
Can a steroid shot into the windpipe protect preemies' lungs?
Prevention CompletedThis trial tests whether giving the steroid budesonide directly into the windpipe, together with surfactant, can prevent bronchopulmonary dysplasia — a chronic lung disease — in very preterm infants (born before 32 weeks or weighing under 1500 grams) who have respiratory distress…
Phase: PHASE4 • Sponsor: Indonesia University • Aim: Prevention
Last updated Jul 26, 2026 00:00 UTC
-
Hospital push could shield seniors from preventable diseases
Prevention CompletedThis trial evaluates whether a hospital-based remedial vaccination strategy can improve Tdap-IPV (tetanus, diphtheria, pertussis, polio) vaccination rates in adults aged 65 and older in the Sarthe region of France. Participants are randomly assigned to receive either the remedial…
Phase: NA • Sponsor: Centre Hospitalier le Mans • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
New shot may shield transplant patients from deadly immune attack
Prevention CompletedThis study tested a drug called abatacept, given as a shot under the skin, to prevent a serious complication called graft-versus-host disease (GVHD) in 29 adults with blood cancers. Participants received a stem cell transplant from a half-matched donor. The goal was to see if aba…
Phase: PHASE1, PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC
-
New antibiotic may replace standard infection prevention in blood cancer patients
Prevention CompletedThis study tested whether fosfomycin, an older antibiotic, works as well as ciprofloxacin for preventing serious infections in people with blood cancers like leukemia or those receiving a stem cell transplant. 177 adults from 11 Spanish hospitals took part. The main goal was to s…
Phase: PHASE3 • Sponsor: Fundación para la Investigación Biosanitaria del Principado de Asturias • Aim: Prevention
Last updated Jun 27, 2026 13:01 UTC
-
Cheap combo may stop pancreatitis after ERCP
Prevention CompletedThis study tested whether giving rectal indomethacin (an anti-inflammatory drug) along with extra fluids before an ERCP procedure could prevent pancreatitis, a painful complication. The trial included 60 patients who needed ERCP. The goal was to see if this simple, low-cost appro…
Phase: PHASE3 • Sponsor: Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondo • Aim: Prevention
Last updated Jun 27, 2026 12:36 UTC
-
Alcohol lock may stop deadly infections in ICU patients
Prevention CompletedThis study tested a 60% ethanol (alcohol) lock solution to prevent serious catheter infections in 1,460 ICU patients with acute kidney failure needing dialysis. The ethanol lock is placed inside the catheter to kill germs. The goal was to see if it reduces major catheter-related …
Phase: PHASE3 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Prevention
Last updated Jun 27, 2026 12:35 UTC
-
Text reminders help get young kids vaccinated on time
Prevention CompletedThis study tested whether sending text message reminders to parents could increase routine vaccination rates in children aged 0-2 years. Over 1,000 families in Brooklyn, New York, whose children were behind on vaccines received texts when shots were due or coming due. The goal wa…
Sponsor: NYU Langone Health • Aim: Prevention
Last updated Jun 27, 2026 12:33 UTC
-
New 'Star Homes' aim to slash childhood disease in tanzania
Prevention CompletedThis study tested whether specially built houses (Star Homes) could reduce malaria, respiratory infections, and diarrhea in children under 13 in rural Tanzania. Over 1,100 children lived either in a Star Home or a traditional mud house. The Star Homes have screened windows, solar…
Phase: NA • Sponsor: University of Oxford • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Heart valve drug shows promise in preventing brain and kidney damage
Prevention CompletedThis study tested a drug called conestat alfa in 141 people undergoing a minimally invasive heart valve replacement (TAVI) for severe aortic stenosis. The goal was to see if the drug could reduce the risk of small strokes and kidney damage that can happen after the procedure. Par…
Phase: PHASE2 • Sponsor: University Hospital, Basel, Switzerland • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
New drug could shield preemie lungs from chronic disease
Prevention CompletedThis early-stage trial tested a new drug called rfhSP-D in 18 premature babies born before 30 weeks. The goal was to find the safest dose that might prevent chronic lung disease, a common complication in preemies. The drug was given along with standard care to babies on breathing…
Phase: PHASE1 • Sponsor: University College, London • Aim: Prevention
Last updated Jun 27, 2026 12:04 UTC
-
Can a simple pill prevent pancreatitis after ERCP? new study tests two drugs
Prevention CompletedThis study tested whether taking oral N-Acetyl cysteine before an ERCP procedure could prevent pancreatitis as well as the standard treatment, rectal diclofenac. Forty-six adults at risk for pancreatitis after ERCP received one of the two drugs. The goal was to see which drug bet…
Phase: PHASE1, PHASE2 • Sponsor: Tanta University • Aim: Prevention
Last updated Jun 27, 2026 11:03 UTC
-
One pill to prevent PTSD? hydrocortisone shows promise after trauma
Prevention CompletedThis study tested whether a single dose of hydrocortisone, given within 6 hours of a traumatic event, could prevent PTSD. 201 trauma survivors from two hospitals received either hydrocortisone or a placebo. Researchers tracked their mental health for 28 weeks to see if the drug r…
Phase: PHASE2 • Sponsor: Rachel Yehuda • Aim: Prevention
Last updated Jun 27, 2026 11:02 UTC
-
Which drug best prevents pancreatitis in kids after ERCP?
Prevention CompletedThis study looked at 192 children having an ERCP procedure to see which drug—rectal indomethacin or IV ketorolac—better prevents post-ERCP pancreatitis. Both are anti-inflammatory medicines given before the procedure. The goal is to find the most effective option for kids.
Phase: PHASE4 • Sponsor: David Vitale MD • Aim: Prevention
Last updated Jun 27, 2026 11:01 UTC
-
Heart surgery kidney shield? stomach drug tested for prevention
Prevention CompletedThis study tested whether giving the acid-reducing drug pantoprazole during heart surgery could prevent acute kidney injury, a common complication. One hundred adults at moderate-to-high risk for kidney damage were randomly assigned to receive either pantoprazole or another acid …
Phase: PHASE2 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Prevention
Last updated Jun 27, 2026 11:00 UTC
-
Virtual reality could open doors to trauma therapy
Symptom relief CompletedThis study tests whether low-cost virtual reality (VR) tools, like 360° video and a new VR Photoscan process, can help people with post-traumatic stress disorder (PTSD) engage more easily with trauma-focused therapy. Participants will receive standard therapy (TF-CBT) either alon…
Phase: NA • Sponsor: Queen's University, Belfast • Aim: Symptom relief
Last updated Aug 18, 2026 02:00 UTC
-
New inflatable cushion could revolutionize ICU patient repositioning
Symptom relief CompletedThis trial tests a new inflatable cushion called the BathMat, designed to help reposition patients lying on their stomachs (proned) in the ICU. Proning helps patients with severe breathing problems get more oxygen, but repositioning them every few hours currently requires at leas…
Phase: NA • Sponsor: Royal United Hospitals Bath NHS Foundation Trust • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Could a High-Fat diet help tame PTSD? tiny german study tests feasibility
Symptom relief CompletedThis study tests whether a medically supervised 12-week ketogenic diet is practical for 6 adults with PTSD in Germany. The main goal is to see if people can stick to the diet and complete the study. It is not designed to measure how well the diet works for PTSD symptoms, but it m…
Phase: NA • Sponsor: Bundeswehr University Munich • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Can music and mindfulness ease the toll of stem cell transplants?
Symptom relief CompletedThis study tests an electronic program that combines mindfulness and music therapy for people undergoing stem cell transplants for blood cancers. The goal is to see if it improves quality of life and reduces symptoms like pain. About 60 adults will participate, and the program in…
Phase: NA • Sponsor: University of Miami • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Could music be medicine for the injured brain?
Symptom relief CompletedThis trial tests whether adding music therapy to standard rehabilitation helps people recover better after serious neurological injuries like stroke, brain injury, or spinal cord damage. About 75 participants aged 16-80 will be randomly assigned to receive either music therapy or…
Phase: NA • Sponsor: University College, London • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Tai chi and tech team up to get heart patients moving
Symptom relief CompletedThis study looks at whether tai chi exercises and wearable fitness trackers can help people who have survived a heart attack (acute coronary syndrome) become more physically active. About 70 adults who are currently inactive will take part. The goal is to see if this approach is …
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC
-
Heart-Smart chemo: new infusion method aims to protect AML patients
Symptom relief CompletedThis early-stage study looked at whether giving two standard chemotherapy drugs (cytarabine and daunorubicin) in a different way could be safer for the heart in adults newly diagnosed with acute myeloid leukemia (AML). Researchers used heart MRI scans to monitor for damage. The g…
Phase: PHASE1 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Intensive therapy during a hospital stay may boost recovery for young trauma survivors
Symptom relief CompletedThis trial tests whether an intensive version of Trauma-Focused Cognitive Behavioral Therapy (TF-CBT), delivered during a hospital stay, helps children and teens aged 11–17 with PTSD after sexual abuse. Researchers compare the inpatient program to standard outpatient therapy to s…
Sponsor: Ankara City Hospital Bilkent • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
Four days to heal trauma? group EMDR put to the test in migrants
Symptom relief CompletedThis pilot trial tests whether a brief group therapy called EMDR-IGTP-OTS can reduce posttraumatic stress symptoms in migrants attending an adult education center in Italy. Participants receive four structured group sessions on consecutive days and are compared with a control gro…
Phase: NA • Sponsor: Azienda Sanitaria Locale Salerno • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
Ear zap may turbocharge athlete recovery
Symptom relief CompletedThis trial tests whether a gentle electrical stimulation of the vagus nerve through the ear (tVNS) can help athletes recover more quickly after intense training. About 121 professional athletes in sports like swimming, athletics, and gymnastics will use the device daily for 60 mi…
Phase: NA • Sponsor: Bakulev Scientific Center of Cardiovascular Surgery • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Could kids have upper limb surgery fully awake? new trial tests the idea
Symptom relief CompletedThis trial tests whether a local anesthetic injection (ropivacaine) can keep children aged 6 to 12 awake and comfortable during upper limb surgery, avoiding general anesthesia. Children watch cartoons on a tablet for distraction while the anesthetic is given. The study aims to se…
Phase: PHASE4 • Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
Could a Two-Session online therapy ease earthquake trauma?
Symptom relief CompletedThis trial tests whether a brief online group therapy called EMDR Flash can help adults who survived the 2023 Kahramanmaraş earthquakes in Türkiye. Participants receive two 60-90 minute group sessions via Zoom and are compared to a waitlist group. The study measures changes in PT…
Phase: NA • Sponsor: Istanbul Galata University • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Cartoon calm: animated film may ease Kids' surgery fears
Symptom relief CompletedThis trial investigates whether a double-reading animated film, watched by both children and their parents before surgery, can reduce anxiety in children aged 3 to 7. The film uses avatars to walk the child through their hospital journey, from room to operating room. Researchers …
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
New breathing device for newborns tested against standard care
Symptom relief CompletedThis study tested two non-invasive breathing machines in 49 newborns (born at 33 weeks or later) with respiratory distress. One machine is the standard nasal CPAP, and the other is a newer device called nasal high frequency percussive ventilation. Researchers measured brain oxyge…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New study tests best way to position ARDS patients to avoid bedsores
Symptom relief CompletedThis study tested two ways of positioning patients with severe lung injury (ARDS) who are on ventilators and placed face-down (prone) to help breathing. The goal was to see if a 'swimmer' position—where the head is turned and one arm is bent—causes fewer severe pressure sores tha…
Phase: NA • Sponsor: University Hospital, Tours • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Simple oxygen trick may protect newborns during emergency intubation
Symptom relief CompletedThis study tested whether giving extra oxygen through a small tube in the nose during breathing tube placement can prevent dangerous drops in oxygen levels in newborns. About 110 infants in the NICU took part. The approach is simple and could make a common emergency procedure saf…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Shock waves ease shoulder pain in new study
Symptom relief CompletedThis study tested a treatment called radial shock wave phonophoresis for people with shoulder impingement syndrome. 70 adults aged 25-40 with shoulder pain were split into two groups: one got shock wave therapy plus standard physical therapy, the other got shock waves alone. The …
Phase: NA • Sponsor: MTI University • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Can acupuncture with electricity boost stroke healing?
Symptom relief CompletedThis study looked at whether electroacupuncture (a type of acupuncture with mild electric pulses) can lower inflammation and help people recover after a stroke. 17 adults who had their first ischemic stroke took part. Researchers measured changes in symptoms and blood markers to …
Phase: NA • Sponsor: China Medical University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Outpatient gallbladder surgery: a satisfying option for some?
Symptom relief CompletedThis study looked at whether emergency gallbladder removal (laparoscopic cholecystectomy) can be performed as an outpatient procedure, meaning patients go home the same day. Researchers measured patient satisfaction using a simple scale. The study enrolled 25 adults with acute ch…
Phase: NA • Sponsor: Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondo • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Acupressure eases heart Patients' anxiety, study finds
Symptom relief CompletedThis study tested whether acupressure, a technique that applies pressure to specific points on the body, can reduce anxiety and improve vital signs like blood pressure and heart rate in people hospitalized with acute coronary syndrome (ACS). Sixty-eight adults with a first-time A…
Phase: NA • Sponsor: Abant Izzet Baysal University • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
New tool helps women with bladder infections skip unnecessary antibiotics
Symptom relief CompletedThis study tested whether a shared decision-making tool could help women with uncomplicated cystitis (bladder infection) and their doctors decide together about antibiotic use. 169 women aged 18-65 participated. The goal was to see if the tool reduced antibiotic use without harmi…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
New oxygen device may help breathing patients between treatments
Symptom relief CompletedThis study tested whether a high-flow oxygen system (Optiflow) works better than a standard oxygen mask for patients with breathing failure. About 100 adults in intensive care who needed non-invasive ventilation (NIV) took part. The goal was to see if Optiflow keeps oxygen levels…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Can a common drug reverse Poison-Induced delirium? new study says yes
Symptom relief CompletedThis study tested whether rivastigmine can safely reverse delirium caused by poisoning from certain drugs like clozapine or tricyclic antidepressants. 100 patients at a poison center received rivastigmine, and doctors measured their consciousness and agitation levels. The goal wa…
Phase: PHASE4 • Sponsor: Alexandria University • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Curcumin vs. hangover: small study tests natural remedy
Symptom relief CompletedThis study tested whether a curcumin supplement (NatureU Cheers Friends Curcumin) could reduce hangover symptoms in 12 healthy adult men. Participants took either the curcumin or a standard hangover product before drinking alcohol, then reported their hangover severity the next m…
Phase: NA • Sponsor: OmniSolutions Laboratory Holdings Limited • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Sedation may ease risky lung exam in breathless patients
Symptom relief CompletedThis study tested whether giving propofol sedation during a lung exam (bronchoscopy) under noninvasive ventilation helps patients with severe breathing failure stay more comfortable and maintain oxygen levels. Forty-six adults with acute respiratory failure needing a diagnostic l…
Phase: PHASE3 • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Trauma recovery showdown: therapy vs. pills for PTSD growth
Symptom relief CompletedThis study looked at whether a special therapy called EMDR or antidepressant medication (SSRIs) helps people with PTSD grow and recover after trauma. 130 adults with PTSD were randomly assigned to one of the two treatments. The main goal was to see which approach leads to more pe…
Phase: NA • Sponsor: Asad Ullah Jan • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
EMDR vs. pills: which works better for PTSD?
Symptom relief CompletedThis completed study tested two common PTSD treatments head-to-head: EMDR therapy (a talking therapy with eye movements) and SSRI antidepressants. Sixty adults with PTSD were randomly assigned to one treatment for six weeks. Researchers measured how many people achieved symptom r…
Phase: NA • Sponsor: Asad Ullah Jan • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Face-Down therapy could save COVID patients who refuse ventilators
Symptom relief CompletedThis study looked at whether lying face down (prone positioning) helps hospitalized COVID-19 patients who have low oxygen levels but are not candidates for breathing machines. About 596 adults took part. The goal was to see if this simple position change could lower the chance of…
Phase: NA • Sponsor: University of Calgary • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Team sedation strategy may shorten ventilator time for kids
Symptom relief CompletedThis study tested a team-based approach to managing sedation in children with acute respiratory failure who need a breathing machine. The goal was to reduce the number of days on the ventilator. Over 2,400 children from multiple hospitals participated, comparing the team approach…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
New dye formula could make emergency gallbladder surgery safer
Symptom relief CompletedThis study tested a personalized dose of a dye called indocyanine green (ICG) to help surgeons see bile ducts more clearly during emergency gallbladder removal. 21 patients with acute cholecystitis received a dye dose calculated from their MRI scans. The goal was to improve surgi…
Phase: NA • Sponsor: Peking Union Medical College Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Vibrating watch may disrupt PTSD nightmares, study finds
Symptom relief CompletedThis study tested a wearable device called NightWare that uses an Apple Watch to detect when a person is having a nightmare and gently vibrates to wake them just enough to stop the nightmare without fully waking them. The trial included 270 veterans and active-duty service member…
Phase: NA • Sponsor: NightWare • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Magnetic pulses may ease Post-Polio symptoms
Symptom relief CompletedThis study tested whether adding transcranial magnetic stimulation (TMS) to standard exercise can reduce fatigue, pain, and improve walking in people with postpolio syndrome. 26 adults who had polio earlier in life and now have new symptoms took part. Half got TMS plus exercise, …
Phase: NA • Sponsor: Ege University • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Online program eases belly pain in kids with pancreatitis
Symptom relief CompletedThis study tested a web-based program to help children aged 10-19 with chronic or recurring pancreatitis manage their abdominal pain. The program teaches cognitive behavioral skills to reduce pain and improve quality of life. 90 participants were enrolled, and the study measured …
Phase: NA • Sponsor: Seattle Children's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Exercise and talk therapy show promise for PTSD relief
Symptom relief CompletedThis small study tested whether 8 sessions of brief exposure therapy combined with moderate exercise can reduce PTSD symptoms in adults. Twelve participants attended twice-weekly sessions for 4 weeks and completed questionnaires. The goal was to see if this treatment is acceptabl…
Phase: NA • Sponsor: Troy Hubert • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Phone calls may boost chemo success in leukemia patients
Symptom relief CompletedThis study tested whether weekly nurse phone calls could help people with chronic lymphocytic leukemia (CLL) stick to their chemotherapy plan and reduce side effects. Sixty patients were split into two groups: one received regular care, and the other also got a weekly call to che…
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Could a blood pressure drug ease Veterans' Post-Concussion headaches?
Symptom relief CompletedThis study tested whether prazosin, a drug used for high blood pressure and PTSD nightmares, can reduce headaches in veterans and service members who had a mild traumatic brain injury. 89 participants received either prazosin or a placebo for 12 weeks. Researchers tracked headach…
Phase: PHASE1, PHASE2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Warm IV fluid eases pain for emergency eye patients
Symptom relief CompletedThis study tested whether warming the intravenous (IV) mannitol fluid before giving it to people with sudden high eye pressure can reduce pain and improve comfort. 142 adults took part, with half getting warmed mannitol and half getting standard (room temperature) mannitol. The g…
Phase: NA • Sponsor: Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Sleep band may help heart patients rest in noisy hospital units
Symptom relief CompletedThis study tested whether wearing an eye-ear sleep band, which blocks light and noise, could improve sleep quality in 100 adults admitted to a coronary care unit with acute coronary syndrome. Each patient spent one night with the band and one night with standard care, in random o…
Phase: NA • Sponsor: Koç University • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Can a virtual snub reveal how racism harms teen health?
Knowledge-focused CompletedThis study looks at whether ethnic minority adolescents who have experienced racial discrimination show stronger biological stress responses when faced with subtle racism. Researchers will measure blood pressure, stress hormones, and other markers while teens take part in a simul…
Phase: NA • Sponsor: Western Kentucky University • Aim: Knowledge-focused
Last updated Aug 18, 2026 02:00 UTC
-
PET scans may reveal hidden leukemia spots before CAR t treatment
Knowledge-focused CompletedThis pilot study tested whether PET-CT scans can detect leukemia that has spread outside the bone marrow in patients with relapsed or hard-to-treat B-cell acute lymphoblastic leukemia (ALL). Ten participants received a PET scan before and after CAR T-cell therapy. The goal was to…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Aug 18, 2026 02:00 UTC
-
AI predicts who will survive lung failure after turning therapy
Knowledge-focused CompletedThis study looks at 377 adults with severe lung failure (ARDS) who were treated with prone positioning (lying face down to help breathing). Researchers will use computer models to predict which patients are at highest risk of dying in the ICU. The goal is to help doctors make bet…
Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Baby breathing machine under the microscope: new study watches how it works
Knowledge-focused CompletedThis study watches how a high-frequency ventilator (Servo-n HFOV) works in real hospital use for babies with severe breathing failure. About 75 infants will be observed to see if the machine safely helps them get enough oxygen and remove carbon dioxide. The goal is to gather info…
Sponsor: Maquet Critical Care AB • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Can a Lung-Opening maneuver change a key injury marker in ARDS?
Knowledge-focused CompletedThis trial investigates whether a recruitment maneuver—a brief procedure to open collapsed lung areas—affects blood levels of sRAGE, a marker of lung cell injury, in patients with diffuse acute respiratory distress syndrome (ARDS). The study involves 24 mechanically ventilated IC…
Phase: PHASE4 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 12, 2026 00:00 UTC
-
Could simply sitting up ease breathing in severe lung failure?
Knowledge-focused CompletedThis study tests whether gradually tilting patients with acute respiratory distress syndrome (ARDS) upright—from lying flat to a 90° seated position—improves how their lungs handle mechanical ventilation. Researchers will measure lung pressure, aeration, and oxygen levels at each…
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Could lung fluid proteins reveal a new way to track severe lung injury?
Knowledge-focused CompletedThis study looks at whether certain proteins linked to the RAGE receptor—found in lung fluid and blood—are elevated in ICU patients with acute lung injury or ARDS. Researchers will measure these proteins in 60 mechanically ventilated patients within the first day of injury and tr…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Could knowing the germs behind summer diarrhea in kids lead to better prevention?
Knowledge-focused CompletedThis study aims to find out which germs cause summer diarrhea in children who visit the emergency room. Researchers will collect stool samples from children aged 0 to 16 and test them for viruses, bacteria, and parasites. The goal is to better understand the causes of these infec…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
Can breathing power boost balance and Well-Being in paralympic athletes?
Knowledge-focused CompletedThis study looks at how lung function, respiratory muscle strength, balance, and quality of life relate in Paralympic athletes. Researchers will measure breathing capacity, muscle strength, and balance in 24 athletes from sports like athletics, swimming, archery, and wheelchair b…
Sponsor: Halic University • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Can a hidden patient reveal why cheap diarrhea treatment is underused?
Knowledge-focused CompletedThis trial investigates why many children with diarrhea do not receive oral rehydration salts (ORS), a simple and inexpensive treatment that can prevent most diarrhea-related deaths. Researchers will send anonymous standardized patients to private healthcare providers, posing as …
Phase: NA • Sponsor: RAND • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Could a platelet-boosting drug shorten recovery after stem cell transplants?
Knowledge-focused CompletedThis study looks back at medical records of people who had an allogeneic stem cell transplant to see whether romiplostim helped their platelets recover faster. Platelets are blood cells that help clotting, and low counts are common after transplant. The researchers will compare p…
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Can simple checks after kidney injury improve recovery?
Knowledge-focused CompletedThis study follows adults who had a severe form of acute kidney injury (AKI) during a hospital stay. Researchers will use non-invasive tests to measure body composition and kidney size, and review medication plans. Participants will also be contacted by phone at 90 days and 12 mo…
Sponsor: Hannover Medical School • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Pre-Surgery sleep patterns linked to Post-Op brain and kidney risks?
Knowledge-focused CompletedThis study looks at whether the way you sleep before heart surgery is connected to problems like confusion (delirium) or kidney damage after the operation. Researchers will track 549 adults having planned heart surgery with a heart-lung machine. The goal is to find patterns that …
Sponsor: Xijing Hospital • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Could a hidden artery condition explain heart attacks in young women?
Knowledge-focused CompletedThis study investigates whether fibromuscular dysplasia (FMD), a condition that causes abnormal growth in artery walls, is more common in people who have had a spontaneous coronary artery dissection (SCAD) — a tear in a heart artery that can cause a heart attack, often in young w…
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Can a Stick-On AI patch replace wires for heart monitoring after surgery?
Knowledge-focused CompletedThis study tests a small, wearable ECG patch that uses artificial intelligence to monitor heart rhythms in patients recovering from cardiac surgery. Participants wear the patch for up to a week after leaving the intensive care unit. The goal is to see if the device can reliably t…
Phase: NA • Sponsor: HUINNO Co., Ltd • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC
-
Can we predict who will relapse after brain inflammation?
Knowledge-focused CompletedThis study examines a rare brain disease called anti-LGI1 encephalitis, where the immune system attacks a protein in the brain, causing memory loss, confusion, and seizures. Researchers will review medical records from 112 patients across five hospitals in Eastern China to see ho…
Sponsor: Shen Chun-Hong • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Alberta launches massive study to improve emergency dialysis care
Knowledge-focused CompletedThis study aims to improve how emergency dialysis is delivered in Alberta hospitals. Researchers will test a new care pathway in 18 intensive care units to see if it can lower costs and improve patient outcomes. About 4,500 adults and children receiving acute dialysis will take p…
Sponsor: University of Alberta • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Fine-Tuning MRI scanners to sharpen the picture of the brain
Knowledge-focused CompletedThis study uses a research-dedicated 3T MRI scanner to develop and optimize imaging protocols in healthy adults. Researchers aim to reduce image distortions, improve contrast and resolution, and create new sequences for functional MRI. The work will help enable future studies in …
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC
-
Arm position during ICU Face-Down care may harm nerves
Knowledge-focused CompletedThis study looks at whether placing patients face-down (prone) to help them breathe can damage nerves in the shoulder area. Researchers will use electrical tests to check for nerve injury in adults with severe lung failure who are sedated and on a ventilator. The goal is to find …
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Massive chest pain registry reveals gaps between guidelines and real-world care in china
Knowledge-focused CompletedThis study analyzes data from over 3 million patients in China's Chest Pain Center registry to understand how people with acute chest pain are diagnosed and treated in real hospitals. It focuses on conditions like heart attacks, unstable angina, aortic dissection, and pulmonary e…
Sponsor: China Cardiovascular Association • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
New dashboard aims to make leukemia trials more inclusive
Knowledge-focused CompletedThis study tests a data visualization tool called the Trial Enrollment Diversity Dashboard (TEDD) designed to help doctors see how diverse their clinical trial enrollments are. The goal is to overcome racial and ethnic disparities in leukemia trial participation. The study enroll…
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Gene expression platform could revolutionize kidney transplant rejection diagnosis
Knowledge-focused CompletedThis study developed and tested HistoMX, an automated platform that analyzes gene activity in kidney transplant biopsy samples. Researchers used over 2,400 archived biopsies from adult kidney transplant recipients to see if the platform could accurately identify different types o…
Sponsor: Paris Translational Research Center for Organ Transplantation • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
New blood test may tell first heart attack from repeat
Knowledge-focused CompletedThis study investigates whether a blood test measuring how platelets clump under high shear forces can distinguish a first acute coronary syndrome from a recurrent one. Researchers will enroll 97 adults with unstable angina or early heart attack. The goal is to see if this test o…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
AI could predict which ICU patients with breathing failure are at highest risk of death
Knowledge-focused CompletedThis study tests whether machine learning can predict death in the intensive care unit for patients with acute hypoxemic respiratory failure (AHRF), a common cause of ICU admission. Researchers will analyze data from over 1,200 patients, using several machine learning algorithms …
Sponsor: Hospital Universitario de Gran Canaria Doctor Negrín • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
Massive study tracks cost and use of heart attack meds in US and germany
Knowledge-focused CompletedThis study analyzes data from over 377,000 people who had a heart attack and were prescribed blood thinners (clopidogrel, ticagrelor, or prasugrel) in Germany and the United States between 2011 and 2024. Researchers aim to describe how often each drug is used and how much it cost…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
Why COVID-19 lungs fail: tiny blood vessel damage may be key
Knowledge-focused CompletedThis study investigates why COVID-19 causes severe lung injury (ARDS) by looking at tiny blood vessels in the lungs. Researchers will compare 39 patients with COVID-19 ARDS to those with ARDS from other causes. They measure 'alveolar dead space' — lung areas that get air but not …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
AI predicts ventilator duration in respiratory failure
Knowledge-focused CompletedThis study tests whether machine learning can predict if a patient with acute hypoxemic respiratory failure will need a breathing machine for a week or longer. Researchers analyzed data from over 1,200 ICU patients in Spain, using information from the first 48 hours to build a pr…
Sponsor: Jesus Villar • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Could low iron be a hidden problem after heart attacks?
Knowledge-focused CompletedThis pilot study looks at how common iron deficiency is in people who have recently had a heart attack. Researchers will test iron levels in up to 70 patients and review their medical records. The goal is to gather early data to plan a larger study on whether treating low iron co…
Sponsor: South Tees Hospitals NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Can a simple score prevent unnecessary hospital stays for chest pain?
Knowledge-focused CompletedThis study tests whether a tool called the HEART score can accurately predict the risk of serious heart problems in people who come to the emergency room with chest pain. The HEART score uses medical history, EKG results, age, risk factors, and a blood test to classify patients a…
Sponsor: University of Monastir • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Breathing new life: tailored ventilation for ARDS patients
Knowledge-focused CompletedThis study investigates whether electrical impedance tomography (EIT) — a non-invasive imaging technique — can help doctors choose the best ventilator settings for each patient with acute respiratory distress syndrome (ARDS). Researchers will compare different methods of setting …
Sponsor: West China Hospital • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Scientists probe why lung disease raises COVID-19 risk
Knowledge-focused CompletedThis study investigates how the immune system responds to COVID-19 in people with chronic lung conditions like asthma, COPD, or cystic fibrosis, compared to those without lung disease. Researchers collect blood, sputum, and nasal samples to measure immune signals and gene activit…
Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Tape measure may spot hidden heart attack danger
Knowledge-focused CompletedThis study looks at whether the neck-to-waist ratio can help identify patients with high blood pressure and a specific type of heart attack. Researchers measured body shapes of 238 adults arriving at the emergency room with chest pain. The goal is to see if simple body measuremen…
Sponsor: Ercis Sehit Rıdvan Cevik State Hospital • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Can genes predict liver damage from childhood cancer drugs?
Knowledge-focused CompletedThis study investigates whether certain genetic differences make children with nephroblastoma (kidney cancer) or acute lymphoblastic leukemia (blood cancer) more likely to develop a serious liver condition called hepatic veno-occlusive disease (VOD) during chemotherapy. Researche…
Phase: NA • Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Contrast dye test reveals hidden kidney damage in ICU survivors
Knowledge-focused CompletedThis study uses a dye called iohexol to measure how well the kidneys are working in patients leaving the intensive care unit after acute kidney failure. The goal is to find out how many patients still have reduced kidney function even though their standard blood tests look normal…
Phase: PHASE3 • Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Breathing test could shorten time on ventilators for lung failure patients
Knowledge-focused CompletedThis study tested a new breathing test to decide when to remove breathing tubes in patients with acute hypoxic respiratory failure. The test uses noninvasive ventilation to see if patients can breathe on their own earlier. Researchers hope this approach reduces time on invasive v…
Phase: NA • Sponsor: West China Hospital • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Ankle test may flag kidney danger after heart surgery
Knowledge-focused CompletedThis study looked at 516 patients who had surgery for a torn aorta (aortic dissection). Researchers checked if a high ankle-brachial index (a simple test of blood flow in the legs) before surgery was linked to kidney problems afterward. The goal was to see if this test could help…
Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Heart attack aftermath: which treatment causes less internal bleeding?
Knowledge-focused CompletedThis study examined bleeding inside the heart muscle (intramyocardial hemorrhage) in 60 patients who had a severe type of heart attack called STEMI. Researchers compared two treatment strategies: giving clot-busting drugs followed by a procedure to open the artery, versus going s…
Phase: NA • Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Nose surgery blood pressure study aims to protect kidneys
Knowledge-focused CompletedThis study looked at 110 adults having nose surgery (septoplasty) to see if different blood pressure targets during surgery affect kidney injury. Patients were split into two groups: one with a lower blood pressure target (50-57 mmHg) and one with a higher target (58-65 mmHg). Ki…
Phase: NA • Sponsor: Fatih Sultan Mehmet Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Breathing machine may harm diaphragm: new study investigates
Knowledge-focused CompletedThis study looks at how breathing machines (mechanical ventilators) might injure the diaphragm, the main muscle used for breathing. Researchers will monitor 50 ICU patients over their first 7 days on the ventilator, measuring diaphragm activity and function. The goal is to unders…
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Researchers hunt for clues to predict deadly pancreas infection
Knowledge-focused CompletedThis study reviewed medical records of 148 adults admitted to the ICU with severe acute pancreatitis. The goal was to find risk factors for infected pancreatic necrosis, a serious complication that raises the risk of death. By identifying these factors, doctors hope to diagnose a…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
New imaging technique may help ventilator settings for lung injury patients
Knowledge-focused CompletedThis study tested a non-invasive imaging method called electrical impedance tomography (EIT) to measure airway opening pressure in 6 adults with acute lung injury or ARDS. The goal was to see if EIT could detect where and when small airways open during a slow breath, which might …
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Simple urine test may predict kidney recovery after acute failure
Knowledge-focused CompletedThis study looked at 287 patients with acute kidney injury caused by tubular necrosis. Researchers measured two substances in urine (PIIINP and NGAL) to see if they could predict whether kidney function would return or if chronic kidney disease would develop. The goal is to find …
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Researchers review CAR T-Cell results in kids with B-ALL
Knowledge-focused CompletedThis study looked back at the medical records of 57 children and young adults (under 25) who received CAR T-cell therapy for B-cell acute lymphoblastic leukemia (B-ALL). The goal was to understand how well the treatment worked and what side effects occurred, especially in those w…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Where is safer for dialysis catheters: ER or dialysis unit?
Knowledge-focused CompletedThis study looked at 398 adults who needed a temporary dialysis catheter, comparing those who got it in the emergency department versus those who got it in the dialysis unit. Researchers tracked infections and blood clots in the catheter for 10 days after placement. The goal is t…
Sponsor: Antalya Health Sciences University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Breath test may warn of kidney danger in ICU
Knowledge-focused CompletedThis study looked at 155 critically ill patients on ventilators to see if the difference between carbon dioxide in their breath and blood could predict acute kidney injury. Researchers measured this gap over the first 24 hours in the ICU. The goal was to find a simple, early warn…
Sponsor: Malatya Egitim Ve Arastirma Hastanesi • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists probe hidden memory system that might survive brain damage
Knowledge-focused CompletedThis completed study looked at how people learn and remember associations, like names or where you met someone. Researchers compared healthy young and older adults with patients who have memory problems from Alzheimer's or semantic dementia. They used memory tests and brain scans…
Phase: NA • Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Tiny tweaks in oxygen targets could help preterm babies breathe better
Knowledge-focused CompletedThis study looked at whether a narrower oxygen saturation target range helps an automated oxygen control system work better for very low birth weight infants on breathing support. Eleven babies were randomly assigned to either a 3% or a shifted 3% target range. The goal was to se…
Phase: NA • Sponsor: Czech Technical University in Prague • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New study examines artery complications in child liver transplants
Knowledge-focused CompletedThis study looked at 583 children who had liver transplants and later developed narrowing or blockage of the liver artery. Researchers wanted to find out how common these problems are and what treatments work best. The goal is to improve care and outcomes for future patients.
Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could natural immune cells help fight leukemia drug resistance?
Knowledge-focused CompletedThis completed study from France examined whether a specific type of immune cell (innate CD8+ T cells) is linked to how quickly resistance mutations develop in patients with chronic myeloid leukemia or Philadelphia-positive acute lymphoblastic leukemia. Researchers analyzed blood…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Breathing therapy may improve lung function in ventilated kids
Knowledge-focused CompletedThis completed study looked at whether a breathing treatment called Intrapulmonary Percussive Ventilation (IPV) can improve lung stiffness (compliance) in critically ill children who are on breathing machines. Researchers measured lung function before and after one IPV session in…
Sponsor: Northwell Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
ICU antibiotics under scrutiny: new study targets hidden brain risks
Knowledge-focused CompletedThis study followed 400 intensive care patients receiving beta-lactam antibiotics to see how often these drugs cause brain-related side effects like confusion or agitation. Researchers measured antibiotic levels in the blood and checked patients' neurological status several times…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
ECMO studied in 761 severe COVID-19 patients: does it help?
Knowledge-focused CompletedThis study looked at whether ECMO, a machine that does the work of the heart and lungs, helps people with severe COVID-19 who have lung failure or heart failure. Researchers tracked 761 patients across France to see how many survived and how quickly they recovered. The goal was t…
Sponsor: Rennes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
ICU kidney danger: new study tracks who gets hurt
Knowledge-focused CompletedThis study looked at 174 adults in the intensive care unit (ICU) to find out how often acute kidney injury happens and what factors make it more likely. Researchers tracked patients who stayed in the ICU for at least 48 hours, excluding those with kidney problems at the start. Th…
Sponsor: Haseki Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Liver failure treatment MARS: does it help avoid transplants?
Knowledge-focused CompletedThis study looked back at the medical records of 27 patients with alcoholic hepatitis or sudden liver failure who received a treatment called MARS (a type of dialysis that cleans the blood). The goal was to see if MARS helped them survive without needing a liver transplant. Resea…
Sponsor: Methodist Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Blood test may forecast kidney comeback in dialysis emergencies
Knowledge-focused CompletedThis completed study looked at 170 adults who needed emergency hemodialysis for acute kidney injury. Researchers measured three blood markers (Activin A, Nostrin, and Angiopoetin-2) before dialysis to see if they could predict whether the kidneys would recover or if the patient w…
Phase: NA • Sponsor: Muğla Sıtkı Koçman University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Kidney risk after lung surgery: new clues from 150 patients
Knowledge-focused CompletedThis study reviewed the records of 150 adults who had surgery to clear blood clots from the lung arteries. Researchers wanted to see who developed kidney injury within two days after surgery and what factors raised that risk. They looked at things like how long the patient was on…
Sponsor: Ebru Girgin Dinc • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Heart attack may leave hidden marks on the brain
Knowledge-focused CompletedThis study looked at 49 adults aged 30-65 who had a first heart attack about 4 months earlier. Researchers used brain scans to see if changes in the brain's blood vessels or structure are linked to memory or thinking problems. The goal is to better understand these issues and hel…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Gene test spots hidden leukemia in kids
Knowledge-focused CompletedThis study looked at 148 children with T-cell acute lymphoblastic leukemia to see if a high-tech gene test could find tiny amounts of cancer left after treatment. Researchers used next-generation sequencing to check for specific gene changes in immune cells. They then compared th…
Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
New nalmefene study could speed up opioid overdose rescue
Knowledge-focused CompletedThis study tested how a new form of nalmefene (a drug that reverses opioid overdoses) behaves in the body when given as a shot or through an IV. 13 healthy adults received single doses of both the new and standard versions. The goal was to see how quickly the drug reaches the blo…
Phase: PHASE1 • Sponsor: Knoa Pharma LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Breathing treatment showdown: no clear winner in lung opening study
Knowledge-focused CompletedThis study looked at two breathing treatments—high-flow oxygen and non-invasive ventilation—in 16 adults with sudden breathing failure from pneumonia. The goal was to see which one better opens up the lungs. The results showed no major difference in lung opening, though non-invas…
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Women's cycle phase linked to mountain sickness risk
Knowledge-focused CompletedThis study looked at whether the phase of a woman's menstrual cycle affects her chances of getting acute mountain sickness (AMS) when traveling to high altitude. Researchers followed 91 healthy women as they spent two days at 3600 meters (about 11,800 feet). The goal was to see i…
Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Late heart attack intervention: helpful or not?
Knowledge-focused CompletedThis study looked at 150 patients who had a heart attack 12 to 36 hours earlier. Researchers wanted to see if opening the blocked artery right away was better than waiting a few days. They used MRI scans to measure heart muscle damage and function.
Phase: NA • Sponsor: Thomas Engstrom • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Kidney check: do current AKI tests really work in the ICU?
Knowledge-focused CompletedThis study looked at 1416 very sick adults in the ICU to see how well different stages of acute kidney injury (AKI) match the kidneys' actual ability to filter waste. Researchers used a urine test to measure kidney function and compared two common ways to diagnose AKI: one based …
Sponsor: University Hospital, Ghent • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Heart ultrasound may predict defibrillator need after heart attack
Knowledge-focused CompletedThis study tested whether a special heart ultrasound (speckle tracking echocardiography) can predict which patients need an implantable defibrillator (ICD) after a large heart attack. Researchers followed 200 patients for 90 days to see whose heart function stayed low enough to q…
Sponsor: Aswan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Scientists hunt for clues to kidney damage in sepsis
Knowledge-focused CompletedThis completed study looked at 211 people with sepsis, some of whom also had acute kidney injury. Researchers measured specific microRNAs and other markers in the blood to understand how kidney damage happens. The goal was to find new targets for diagnosis or treatment, not to te…
Sponsor: University Hospital Ostrava • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Study aims to Fine-Tune oxygen delivery for sick infants
Knowledge-focused CompletedThis study measured the peak tidal inspiratory flow (PTIF)—how fast infants breathe in—in 50 babies under 6 months old with moderate to severe viral bronchiolitis. Researchers used a spirometer to record 20 breaths per infant within 24 hours of hospital admission. The goal was to…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Can your genes predict blood thinner success? new study targets caribbean hispanics
Knowledge-focused CompletedThis study looked at 150 Caribbean Hispanic adults with heart disease or stroke risk who take the blood thinner clopidogrel. Researchers wanted to see if certain gene variants affect how well the drug works. The goal is to understand why some people get less benefit and to pave t…
Phase: EARLY_PHASE1 • Sponsor: University of Puerto Rico • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Tapping away trauma? brain study hints EMDR technique may calm emotional reactivity
Knowledge-focused CompletedThis study tested whether a single 15-minute session of Butterfly Tapping, a self-administered EMDR technique, could change brain activity in 46 young adults with PTSD. Participants either did the tapping or sat still while their brain waves were recorded. The tapping group showe…
Phase: NA • Sponsor: University of Rome Foro Italico • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
New study tracks immune cell function after stem cell transplants to personalize care
Knowledge-focused CompletedThis completed study looked at how immune cells recover in 61 adults who received a stem cell transplant for blood cancers. Researchers measured the function of T and NK cells by testing their cytokine profiles after stimulation. The goal was to see if these measurements could he…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Can a gut feeling save lives? ICU study tests simple predictions
Knowledge-focused CompletedThis study looked at 800 emergency ICU patients to see if simple checks and gut feelings from nurses and students can predict who will survive, just as well as complex scoring systems. The goal was to collect data and compare different prediction methods to find the easiest and m…
Sponsor: University Medical Center Groningen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Which breathing support works best after extubation? small study investigates
Knowledge-focused CompletedThis study looked at 13 adults who had been on a breathing tube for at least 2 days and were at risk for breathing trouble after the tube was removed. Researchers compared two types of noninvasive breathing support: one that senses the patient's own breathing signals (NAVA) and o…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Tiny sleep study hopes to unlock breathing problems in COVID ICU survivors
Knowledge-focused CompletedThis study looked at whether neck muscle activity during sleep affects breathing recovery in 17 COVID-19 patients who were on ventilators in the ICU. Researchers used sleep tests and activity monitors to track sleep quality and breathing patterns. The goal was to understand why s…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Are cirrhosis patients getting the shots they need? french study finds out
Knowledge-focused CompletedThis study looked at how many people with cirrhosis in French general hospitals were vaccinated against diseases like hepatitis, flu, and COVID-19. Researchers surveyed 742 patients to see if they were up to date on their shots. The goal was to find gaps in vaccination coverage s…
Sponsor: Centre Hospitalier Sud Francilien • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Can a smartphone app save more newborns? large study tests real-time feedback for resuscitation
Knowledge-focused CompletedThis study tested whether a mobile health app called LIVEBORN can help nurse midwives improve how they support newborns who have trouble breathing right after birth. Over 14,000 newborns and their nurses took part. The app gave either real-time guidance or a summary after the eve…
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Heart attack study reveals why every minute counts
Knowledge-focused CompletedThis study tracked 555 adults hospitalized with acute coronary syndrome (a serious heart condition) to see how quickly they called for help and what factors influenced their recovery. Researchers focused on delays in calling an ambulance and how those delays affected short- and l…
Sponsor: National Medical Research Center for Therapy and Preventive Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Can a simple ultrasound test predict who needs fluids in the ICU?
Knowledge-focused CompletedThis study looked at 50 ICU patients with acute respiratory failure to see if a heart ultrasound test (measuring how the main vein collapses) could predict who would die or need a breathing tube. The goal is to help doctors give fluids more safely. It was an observational study, …
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Antibiotics before kidney drainage: help or hype?
Knowledge-focused CompletedThis study looked at whether giving antibiotics before a kidney drainage procedure (called percutaneous nephrostomy) prevents urinary tract infections in cancer patients whose urinary tract is blocked by a tumor. Researchers reviewed records of 320 cancer patients who had the pro…
Sponsor: Barretos Cancer Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
AI breathes new life into pediatric ICU ventilator care
Knowledge-focused CompletedThis completed study tested whether an AI system could improve how ventilators are set for children (ages 1 month to 18 years) in the pediatric ICU with breathing problems like pneumonia or respiratory failure. Researchers compared AI-generated recommendations to the actual adjus…
Sponsor: Wu Rongzhou • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
New 10-Question test could spot PTSD in car crash survivors
Knowledge-focused CompletedThis study tested a 10-item questionnaire called DEPITAC, designed for nurses to screen road traffic accident patients for post-traumatic stress disorder (PTSD) while they are still in the surgical unit. Researchers enrolled 274 hospitalized accident victims to see if the simple …
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
New ultrasound technique aims to better measure liver health
Knowledge-focused CompletedThis study tested a new ultrasound technique called ARFI to measure liver stiffness in 109 people, including healthy volunteers and patients with liver conditions. The goal was to understand normal stiffness values and how they change with disease or treatment. This is an observa…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Mold infection risk in kids with leukemia: a 14-year review
Knowledge-focused CompletedThis study looked back at 621 children in Denmark who had chemotherapy for acute leukemia between 2008 and 2022. The goal was to find out how many got serious mold infections and what factors made it more likely. The results will help doctors better protect children during treatm…
Sponsor: University of Southern Denmark • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Heart surgery study questions routine use of ultrasound probe
Knowledge-focused CompletedThis study looked at whether using a heart ultrasound probe (TEE) during low-risk coronary artery bypass surgery should be done routinely or only when needed. Researchers enrolled 40 patients and checked if it was possible to randomly assign them to one of two groups. The goal is…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New surgical clip tool tested in 161 patients
Knowledge-focused CompletedThis study looked at a new device called AE05ML that helps surgeons place clips on blood vessels and other tissues during keyhole surgery. The goal was to see if the device is safe and works well. A total of 161 adults took part in the study.
Sponsor: Teleflex • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Blood marker may flag surgery danger for seniors
Knowledge-focused CompletedThis study looked at nearly 30,000 older adults (65+) having non-cardiac surgery to see if levels of homocysteine, a natural amino acid, could predict serious complications like kidney injury or death. Researchers measured homocysteine before and after surgery. The goal was to se…
Sponsor: Chinese PLA General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Can better sleep help kids in the ICU recover faster?
Knowledge-focused CompletedThis study looked at ways to improve the care, environment, and daily routines of children in the pediatric intensive care unit (PICU) to support their healing and natural sleep-wake cycles. Researchers observed 56 children aged 6 months to 18 years who were on breathing machines…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Ultrasound could help doctors manage fluids during kidney treatment
Knowledge-focused CompletedThis study looked at 100 critically ill adults with severe kidney failure who were receiving continuous kidney replacement therapy. Researchers used a special ultrasound technique to check for fluid buildup in the body, which can harm organs. The goal was to see how common fluid …
Sponsor: Chulalongkorn University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Could a simple gas reduce lung damage in ventilator patients?
Knowledge-focused CompletedThis study tested whether giving a gas sedative (isoflurane) instead of standard IV drugs could reduce the energy delivered to the lungs by the breathing machine in 40 ICU patients. The goal was to see if this approach might lower the risk of lung injury. The trial was small and …
Phase: NA • Sponsor: Mahidol University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
New study aims to protect hearts of ARDS patients on ventilators
Knowledge-focused CompletedThis study looked at 10 adults with moderate-to-severe ARDS who were on breathing machines. Researchers used a non-invasive imaging method (EIT) to adjust ventilator pressure settings and then checked how the heart's right side responded using ultrasound. The goal was to find the…
Phase: NA • Sponsor: University of Padova • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Tiny pressure difference could save lungs on ventilators
Knowledge-focused CompletedThis study looked at 500 adults on breathing machines to see if measuring airway pressure at a specific moment (P1) versus a later moment (P2) better predicts lung damage. The goal is to find which measurement helps doctors set safer ventilator settings. No new treatment was test…
Sponsor: University of Padova • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Face-Down breathing: new study tests simple position change for COVID-19 lung failure
Knowledge-focused CompletedThis study looked at whether lying face down (prone position) while awake can improve how air moves through the lungs in COVID-19 patients with breathing failure. Twenty adults with COVID-19 and low oxygen levels were monitored using a special imaging technique (EIT) to measure l…
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Blood test may predict heart attack Patients' future risk
Knowledge-focused CompletedThis study looked at whether certain cells and substances in the blood can help predict if a person who has had a heart attack or unstable angina will have another heart problem within a year. Researchers took blood samples from 180 patients and tracked their health for one year.…
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Ultrasound may spot preterm babies needing lung treatment earlier
Knowledge-focused CompletedThis study looked at whether chest ultrasound can predict which premature babies (born before 34 weeks) will need surfactant—a substance that helps their immature lungs work better. Doctors currently decide based on oxygen levels, which can delay treatment. Researchers performed …
Sponsor: South Tees Hospitals NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
COVID ICU survivors: does lying on your belly help years later?
Knowledge-focused CompletedThis study checks on 137 COVID-19 patients who were in the ICU and used awake prone positioning (lying on their belly) while on high-flow oxygen. Researchers want to see if this technique affects quality of life and survival more than two years later. Participants answer a phone …
Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Leukemia Patients' hidden threat: fungal infections under microscope
Knowledge-focused CompletedThis study observed 150 adults with a specific type of leukemia (Ph-negative ALL) to see how many developed serious fungal infections during their first weeks of chemotherapy. Researchers tracked infection rates and deaths linked to these infections. The goal was to better unders…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Heart scan may predict recovery after heart attack
Knowledge-focused CompletedThis study looked at 30 people who had a heart attack and were treated with a procedure to open blocked arteries. Researchers used a special heart scan soon after treatment to see how much heart muscle was saved. They then checked if that scan could predict how well the heart wou…
Sponsor: Fayoum University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Blood clot markers may predict severe pancreatitis
Knowledge-focused CompletedThis completed study looked at 141 people with acute pancreatitis to understand how blood clotting changes during the illness. Researchers took blood samples over several days and will analyze them for markers that might predict whether the disease becomes mild, moderate, or seve…
Sponsor: Region Skane • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Running and swimming may temporarily stress kidneys, study finds
Knowledge-focused CompletedThis study looked at how a 10 km run and a 1.5 km swim affect kidney function in 40 healthy, active adults. Researchers used sensitive urine tests to detect subtle kidney changes that standard blood tests might miss. The goal was to better understand temporary kidney stress from …
Phase: NA • Sponsor: Hospital Clínico Universitario de Valladolid • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
New drug EP395 tested in humans for first time
Knowledge-focused CompletedThis early-stage study tested the safety and tolerability of a new drug called EP395 in 78 healthy adults aged 18-65. Participants received either EP395 or a placebo capsule, and researchers monitored side effects, vital signs, and hearing. The goal was to find a safe dose range …
Phase: PHASE1 • Sponsor: EpiEndo Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Massive study reveals Real-World impact of respiratory failure in china
Knowledge-focused CompletedThis study observed over 4,000 patients in Chinese ICUs who needed breathing support for acute respiratory failure. Researchers tracked treatments, outcomes, and costs to better understand the disease burden. The goal is to improve care and identify risk factors, not to test a ne…
Sponsor: Southeast University, China • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Real-World data on CPAP for COVID-19 respiratory failure
Knowledge-focused CompletedThis study looked at how well CPAP therapy works for COVID-19 patients who have trouble breathing. Researchers collected data from 250 patients in a hospital to see how they responded to treatment. The goal was to learn more about managing severe COVID-19 in real-life settings.
Sponsor: University of Milan • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
New study maps antibiotic resistance in bile duct infections to guide smarter treatment
Knowledge-focused CompletedThis study looked at 1435 patients with acute cholangitis (a bile duct infection) who had an ERCP procedure. Researchers analyzed bile samples to understand which bacteria were causing the infections and how resistant they were to antibiotics. The goal was to find patterns that c…
Sponsor: Emergency County Hospital Pius Brinzeu; Timisoara, Romania • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
New nasal cannula design may ease breathing in respiratory failure
Knowledge-focused CompletedThis study tested whether an asymmetrical high-flow nasal cannula reduces the work of breathing compared to a conventional one in 40 patients with acute respiratory failure. Participants received both devices at different flow rates, and researchers measured diaphragm and chest m…
Phase: NA • Sponsor: Siriraj Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Which IV fluid spares kidneys best during back surgery in seniors?
Knowledge-focused CompletedThis study looked at 174 older adults (ages 65-80) having lumbar fusion surgery to see whether using sodium acetate Ringer's solution or sodium lactate Ringer's solution during the operation better protects the kidneys. Researchers measured early kidney injury markers in urine an…
Phase: NA • Sponsor: Xianping Wu • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
One year later: how Kids' lungs heal after ARDS
Knowledge-focused CompletedThis study followed 38 children who survived acute respiratory distress syndrome (ARDS), a severe lung condition. One year after leaving the hospital, researchers checked for lasting breathing problems like cough, wheeze, and lung stiffness using scans and tests. The goal was to …
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Heart attack recovery: do women and men get equal prevention care?
Knowledge-focused CompletedThis completed study looked at 530 heart attack survivors from 25 Spanish hospitals to see if women and men differ in how well they follow prevention advice, like taking medications, eating healthy, exercising, and joining rehab programs. Researchers matched women and men by age …
Sponsor: Spanish Society of Cardiology • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Can VR keep kids active and engaged after school? new study explores
Knowledge-focused CompletedThis study tested a virtual reality (VR) afterschool program for 32 children ages 9-17. The goal was to see if kids would use and enjoy the VR system, and to measure their physical activity. This was a pilot study to gather information, not to treat or cure any disease.
Phase: NA • Sponsor: University of Georgia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Scientists hunt for hidden signs in blood cancers to personalize treatment
Knowledge-focused CompletedThis study collected blood, bone marrow, skin, and cheek cell samples from 650 adults with acute leukemia, myelodysplastic syndromes, or myeloproliferative disorders. Researchers analyzed the samples to find genetic, epigenetic, and drug sensitivity patterns that might predict ho…
Phase: NA • Sponsor: Institut Paoli-Calmettes • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Scientists collect kidney samples from COVID-19 patients to uncover clues about organ damage
Knowledge-focused CompletedThis completed study collected blood, urine, and kidney tissue from 90 COVID-19 patients with acute kidney injury. Researchers aimed to build a biorepository and analyze samples to better understand how COVID-19 affects the kidneys. The goal is to speed up discoveries and improve…
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Eye infection study: does early surgery save sight better than drugs?
Knowledge-focused CompletedThis study looked back at 170 adults with a serious eye infection called endophthalmitis to see if early surgery (within 48 hours) helps vision more than starting with medicine alone. Researchers compared how well people could see one month after treatment. The goal is to find ou…
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Gut check: could your microbiome predict heart attack outcomes?
Knowledge-focused CompletedThis study looked at the gut bacteria of 200 heart attack patients, comparing those with high blood sugar to those with normal levels. Researchers collected stool samples before treatment and again at 6 and 12 months to see if changes in gut bacteria relate to survival. The goal …
Sponsor: University of Campania Luigi Vanvitelli • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Tiny heart probe may predict lung recovery
Knowledge-focused CompletedThis study tested whether a miniaturized ultrasound probe placed in the esophagus could help predict outcomes in 50 patients with acute respiratory distress syndrome (ARDS). The probe measures a blood vessel collapse index that may indicate heart strain. Researchers tracked how m…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Study aims to unlock secrets of lung failure in kids
Knowledge-focused CompletedThis study looked at 513 children with a severe lung condition called ARDS to find different subtypes of the disease. Researchers collected blood samples to measure proteins and gene activity. The goal was to better understand the disease and help design more targeted treatments …
Sponsor: Children's Hospital of Philadelphia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
New study tracks COVID vaccine durability in chronic illness patients
Knowledge-focused CompletedThis completed study followed 360 adults and children with chronic respiratory and other medical conditions to see how their immune systems responded to COVID-19 vaccines over 18 months. Researchers measured antibody, T cell, and B cell levels before vaccination and every 3 month…
Sponsor: National Jewish Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
Tiny lungs, big comparison: which breathing aid works best for preemies?
Knowledge-focused CompletedThis study looked at how two different breathing devices affect the lungs of extremely low birth weight babies. Researchers compared a high-flow nasal cannula to nasal CPAP in 80 stable premature infants. They measured lung function using a special imaging technique to see which …
Phase: NA • Sponsor: Sharp HealthCare • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
New test could spot transplant rejection without a biopsy
Knowledge-focused CompletedThis study looked at whether proteins in ostomy fluid (waste from the intestine) can signal rejection after an intestinal transplant. Currently, doctors must take tissue samples through a scope to check for rejection, which is invasive and not always accurate. Researchers analyze…
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
New ventilator approach studied in ARDS patients
Knowledge-focused CompletedThis study looked at a new way to set breathing machines for people with severe lung injury (ARDS). The method uses pressure measurements inside the lungs to adjust settings. Nine adults took part to see if the approach is safe and works well. The goal was to learn more, not to c…
Phase: NA • Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
New naloxone spray tested for faster overdose help
Knowledge-focused CompletedThis study tested a new device (AP003) that delivers naloxone as a nasal spray to reverse opioid overdoses. Twenty-four healthy adults received multiple doses to see how the drug moves through the body and to check for side effects. The goal was to compare the new spray with an e…
Phase: PHASE1 • Sponsor: Emergent BioSolutions • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
New study reveals hidden kidney risks in liver cirrhosis patients
Knowledge-focused CompletedThis study looked at how often acute kidney injury happens in people with liver cirrhosis, and what factors might increase the risk. Researchers at Sohag University Hospital followed 180 adult patients with cirrhosis, excluding those with pre-existing kidney disease or other majo…
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Blood test could predict leukemia survival
Knowledge-focused CompletedThis study tests whether measuring two substances in the blood—FLT3L and IL-6—during chemotherapy can help predict survival in people with acute myeloid leukemia (AML). Researchers will track 201 newly diagnosed AML patients across 25 French hospitals. The goal is to confirm that…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Inflammation clues after heart attack could predict future risks
Knowledge-focused CompletedThis study looked at 100 people who had a heart attack to see if certain inflammation markers in the blood could predict who might die or develop heart failure within 6 months. Researchers measured these markers at several time points after the attack. The goal was to better unde…
Sponsor: Nicosia General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
CAR-T therapy Follow-Up study shows no new safety surprises
Knowledge-focused CompletedThis study followed 16 people who had already received a special immune cell treatment (CLBR001 CAR-T) for various types of B-cell blood cancers like lymphoma and leukemia. The goal was to check for any new or long-term side effects that might appear months or years after treatme…
Phase: PHASE1 • Sponsor: Calibr, a division of Scripps Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Hunt for tick virus in limousin: 878 tested
Knowledge-focused CompletedThis completed study tested blood samples from 878 people in Limousin, France, for antibodies against tick-borne encephalitis virus (TBEV). The goal was to see if the virus is present in the region, especially in patients with Lyme disease or neurological symptoms. Researchers al…
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Can a computer predict overdose outbreaks? rhode island trial tests new tool
Knowledge-focused CompletedThis study tested a predictive analytics tool called PROVIDENT to forecast where overdose deaths might happen next. Researchers randomly assigned 39 Rhode Island municipalities to either use the tool or continue with standard prevention efforts. The goal was to see if directing r…
Phase: NA • Sponsor: Brown University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Biomarker may forecast kidney disease risk after acute injury
Knowledge-focused CompletedThis completed study looked at whether levels of a protein called angiotensinogen in blood and urine can predict long-term kidney function in people who had acute kidney injury. Researchers followed 80 patients for three years to see if this biomarker could help identify those at…
Sponsor: Sanliurfa Mehmet Akif Inan Education and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Blood test may forecast heart risks in shock patients
Knowledge-focused CompletedThis study looked at 264 patients who had a heart attack complicated by cardiogenic shock. Researchers examined whether the ratio of red blood cell distribution width to albumin (RAR) in the blood could predict major heart problems like death, another heart attack, or stroke duri…
Sponsor: Xuzhou Central Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Telehealth may speed heart attack care, small study suggests
Knowledge-focused CompletedThis study looked at whether a telehealth program could help paramedics treat people having a severe heart attack (STEMI) more quickly. Researchers measured times from first contact to treatment in 11 patients in Wilkes County. The goal was to see if remote support from doctors c…
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Manikin study tests best way to start CPR in kids
Knowledge-focused CompletedThis completed trial compared two ways to start CPR in a simulated child cardiac arrest: starting with chest compressions (AHA method) versus starting with rescue breaths (ERC method). Researchers used a manikin to measure how much air reached the lungs in the first minute. 28 he…
Phase: NA • Sponsor: Geneve TEAM Ambulances • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Massive study reveals hidden toll of ICU on ARDS survivors
Knowledge-focused CompletedThis study reviewed medical records of over 640,000 people in the US who had acute respiratory distress syndrome (ARDS) and were in the ICU. Researchers wanted to find out what new health problems—physical, mental, or emotional—arise after such a stay, known as post-intensive car…
Sponsor: Bayer • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Does extra oxygen during heart surgery protect kidneys? new pilot study investigates.
Knowledge-focused CompletedThis pilot study looked at whether giving extra oxygen during heart surgery (when a heart-lung machine is used) affects kidney function afterward. 104 adults having elective heart surgery were randomly assigned to receive either high or normal oxygen levels. The main goal was to …
Phase: NA • Sponsor: University of Padova • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
New ventilator mode tested in lung injury patients
Knowledge-focused CompletedThis study tested a new breathing machine mode called NAVA in 15 patients recovering from acute lung injury. The goal was to see how their bodies responded to different levels of support from the machine. The study did not aim to treat or cure the lung injury, but to gather infor…
Phase: NA • Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Could a simple oxygen change help ICU patients breathe easier after tube removal?
Knowledge-focused CompletedThis study tested whether giving high-flow oxygen through the nose just before removing a breathing tube is safe and acceptable for patients in intensive care with severe breathing problems. Only 2 patients took part, and the main goal was to see if a larger study is possible. Th…
Phase: NA • Sponsor: NHS Greater Glasgow and Clyde • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
AI reads heart patient records faster than doctors?
Knowledge-focused CompletedThis study tested an AI system that reads medical records of 308 heart disease patients and pulls out key information like test results and diagnosis types. The AI's accuracy was compared to that of seven doctors. The goal was to see if AI can help make clinical data collection f…
Sponsor: China National Center for Cardiovascular Diseases • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Emergency surgery in pregnancy: new study aims to understand fetal outcomes
Knowledge-focused CompletedThis study looked at how emergency general surgery affects pregnant women and their unborn babies. Researchers planned to follow pregnant women who needed surgery for problems like appendicitis or gallbladder disease. The goal was to learn more about the safety of these surgeries…
Sponsor: Methodist Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Blood protein may warn of kidney danger in sepsis
Knowledge-focused CompletedThis completed study looked at whether a protein called vasorin in the blood can help predict how severe kidney injury will be in people with septic shock. Researchers took blood samples from 50 intensive care patients on day 0 and day 3. The goal was to see if vasorin levels are…
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Hospital heparin use under the microscope: did they follow the rules?
Knowledge-focused CompletedThis study looked at how well hospitals follow the standard protocol for giving heparin, a blood thinner, to patients with blood clots or heart issues. Researchers checked 100 patients to see if their heparin doses were adjusted correctly based on blood test results. The goal was…
Sponsor: Methodist Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Massive global study maps kidney injury in sick kids
Knowledge-focused CompletedThis study looked at over 5,000 critically ill children from hospitals worldwide to learn more about acute kidney injury (AKI). The goal was to better understand how common AKI is, what puts children at risk, and how to predict it using a tool called 'renal angina.' The study did…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
ER study sheds light on hidden xylazine in opioid overdoses
Knowledge-focused CompletedThis study measured the amount of xylazine—a dangerous animal sedative often mixed with opioids—in the blood and urine of 75 emergency room patients who had a non-fatal opioid overdose. The goal was to see how common xylazine is and how well test strips can detect it. The finding…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Researchers review best acyclovir dose for obese patients with rare brain infection
Knowledge-focused CompletedThis completed study reviewed medical records of 50 obese adults with HSV encephalitis (a brain infection) to see how different ways of calculating acyclovir dose affect survival. Researchers looked at patients treated between 2013 and 2019 at six hospitals. The goal was to find …
Sponsor: Methodist Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Blood test may predict COVID-19 severity, study finds
Knowledge-focused CompletedThis study looked at whether a blood test measuring suPAR levels can predict which adults hospitalized with COVID-19 will develop severe breathing failure requiring a breathing tube. Researchers analyzed stored blood samples from about 367 patients. The goal was to see if a suPAR…
Sponsor: ViroGates A/S • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Heart Infection's hidden brain damage tracked over time
Knowledge-focused CompletedThis study followed 100 patients who had infectious endocarditis, a serious heart infection, to see how brain lesions found on MRI scans change over time. Researchers compared initial MRI results with follow-up scans and tested thinking and memory skills. The goal was to understa…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Ambulance blood test may speed up heart attack triage
Knowledge-focused CompletedThis study combined data from over 5,000 people to see if a simple blood test (troponin) and risk scores used by paramedics can accurately identify those having a heart attack before they reach the hospital. The goal is to improve how patients are triaged and treated early. No ne…
Phase: NA • Sponsor: Catharina Ziekenhuis Eindhoven • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
New lung monitor for tiny babies shows promise in early test
Knowledge-focused CompletedThis study tested a new device called Neola® that monitors the lungs of newborn babies. Ten preterm and term infants were enrolled to see if the device is safe and works well. The main goal was to check for any skin reactions or other side effects.
Phase: NA • Sponsor: Neola Medical AB • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Heart attack patients monitored for new AFib risk
Knowledge-focused CompletedThis completed study tracked 832 heart attack patients in China who developed new-onset atrial fibrillation during their hospital stay. Researchers used continuous heart monitoring to see how the amount of AFib affected risks like death, another heart attack, or heart failure. Th…
Sponsor: Shanghai 10th People's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Can a simple screen get seniors moving in hospital?
Knowledge-focused CompletedThis study tracked how much older adults (65+) move during a hospital stay and tested whether a screen showing real-time activity to staff could encourage more movement. Researchers also validated a Danish version of a mobility assessment. The goal is to help hospitals better sup…
Sponsor: Copenhagen University Hospital, Hvidovre • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
New imaging sheds light on hidden heart clots after attack
Knowledge-focused CompletedThis study looked at 100 people who recently had a major heart attack to better understand blood clots that can form in the heart's main pumping chamber. Using special PET/MR scans, researchers tracked clot activity in the heart and brain over several months. The goal was to lear…
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Can simple breathing exercises help ICU patients get stronger?
Knowledge-focused CompletedThis study tested whether a combined breathing muscle training program is safe and practical for adult ICU patients who are on or recently off a ventilator. Twenty-two patients received the training alongside usual care. The main goal was to see if patients could stick with the p…
Phase: NA • Sponsor: Royal College of Surgeons, Ireland • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Life-Saving dialysis may strip essential nutrients, study warns
Knowledge-focused CompletedThis study looked at 43 critically ill adults with acute kidney injury who needed continuous kidney replacement therapy (CRRT). Researchers measured how much of certain nutrients—like carnitine, vitamins, and amino acids—were removed during dialysis. The goal was to understand if…
Sponsor: Gulhane Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Early heart scans may help kidney patients live longer and delay dialysis
Knowledge-focused CompletedThis study reviewed medical records of 139 people with advanced chronic kidney disease who had a heart attack. Researchers wanted to see if getting a coronary angiogram (a special X-ray of the heart arteries) soon after the heart attack was linked to living longer and needing dia…
Sponsor: Chulalongkorn University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Dialysis lock leak study raises safety questions
Knowledge-focused CompletedThis study looks at whether heparin or citrate locks used in dialysis catheters leak into the bloodstream. It involves 76 adults with acute kidney failure. Researchers measure blood clotting and calcium levels before and after injecting the lock to check for leakage and potential…
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Tiny tweak to ventilator settings could improve breathing for sick newborns
Knowledge-focused CompletedThis study looked at how changing the speed at which a ventilator reaches its target pressure affects breathing in 17 newborns on breathing support. The researchers tested different settings and measured changes in airway pressure and gas exchange. The goal was to find out if thi…
Phase: NA • Sponsor: Hacettepe University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Heart attack bleeding linked to dangerous rhythms after stent procedure
Knowledge-focused CompletedThis completed study looked at 250 adults who had a severe type of heart attack (STEMI) treated with a stent. Researchers used portable heart monitors to check how often dangerous heart rhythms occurred in people whose heart attack involved bleeding. The goal was to better unders…
Sponsor: Rohan Dharmakumar • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Heart attack drug safety under scrutiny: new study examines bleeding risks
Knowledge-focused CompletedThis completed study looked at over 6,000 heart attack patients to see how different antiplatelet medications affect the risk of bleeding inside the heart. Researchers compared outcomes like heart-related events, bleeding complications, and death within 30 days. The goal is to he…
Sponsor: Rohan Dharmakumar • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
New study tracks kidney health in myeloma patients on daratumumab
Knowledge-focused CompletedThis study measured certain proteins in the blood and urine of 20 newly diagnosed multiple myeloma patients before and 30 days after starting daratumumab. The goal was to see if these markers could help detect early kidney injury. Participants provided samples during routine lab …
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Heart attack Patients' bleeding risk tracked after blood thinner switch
Knowledge-focused CompletedThis study followed over 1,000 people who had a heart attack and were given a quick-acting intravenous blood thinner called cangrelor during a procedure to open blocked arteries. Researchers wanted to see how often bleeding occurred when patients then switched to a different oral…
Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC